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Intrinsically disordered regions (IDR) are protein segments that lack a defined 
tertiary structure. IDRs are enriched in eukaryotic chromatin-binding proteins, where they 
modulate protein-DNA and protein-protein interactions. In this thesis, I probe the 
function(s) of IDRs via two case studies: the yeast mismatch repair (MMR) protein Mlh1-
Pms1 and transcription factors (TFs) derived from C. albicans, a pathogenic yeast. Using 
single-molecule DNA curtain assays, I demonstrate novel roles for IDRs in promoting 
facilitated diffusion of Mlh1-Pms1 on DNA. IDRs improve Mlh1-Pms1’s ability to bypass 
a single nucleosome and to navigate dense nucleosome arrays that resemble chromatin. 
Moreover, these IDRs are critical for the Mlh1-Pms1 ATPase activity and also for nicking 
of the DNA substrate. I propose that conformational changes in the Mlh1-Pms1 IDRs alter 
DNA interactions and the nucleolytic activity of neighboring structured domains. I also 
examine the dynamics of PCNA, another essential MMR factor, in the context of 
trinucleotide repeat (TNR) instability. I show that Replication Factor C preferentially loads 
PCNA onto (CAG)13 structures. The (CAG)13 repeat captures the loaded PCNA and 
prevents PCNA from diffusing. Lastly, I reveal a novel role for IDRs in DNA condensation 
by studying Efg1, a TF that regulates a cell-type switching network in C. albicans. Efg1 
encodes a specific IDR of low complexity, referred to as the prion-like domain (PrLD). I 
	
vii	
show that the PrLD is critical for the DNA condensation and recruiting other PrLD-
containing TFs, wherein nucleosomes regulate the TF-DNA dynamics. I propose a model 
where transcription factors become concentrated via phase separation and bring gene 
regulatory elements together to promote gene activation. Overall, this study provides 
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Chapter 1: Introduction 
 
Intrinsically Disordered Regions in Chromatin-Binding Proteins 
 
Significance of intrinsically disordered regions 
 Proteins encode both structured domains and intrinsically disordered regions (IDR) 
(Figure 1.1A). Structured domains undergo cooperative folding into a unique tertiary 
conformation. In contrast, IDRs are incapable of folding into a well-defined three-
dimensional (3D) structure. This is because IDRs do not have an amino acid composition 
that can provide long-range hydrophobic interaction to mediate cooperative folding. 
Instead, IDRs are typically comprised of a higher portion of polar and charged residues or 
low sequence complexity (1). At least 30% of the eukaryotic proteome is comprised of 
IDRs (Figure 1.1B). In contrast to structured domains, however, it was not until recently 
that IDRs were recognized as a critical region for contributing to proteins’ roles in cells.  
 IDRs can be found in any part of a protein, including carboxyl- and amino-terminal 
regions, or present as linkers connecting structured domains. The length of IDRs can span 
from ~10 to hundreds of amino acid residues. No matter what the position or length of an 
IDR is, it is useful to classify IDRs based on their biological functions. In this section, I 
will first describe established ideas about how IDRs contribute to protein function. I will 
then discuss chromatin-binding proteins by focusing on their IDRs and target search 
activity.   
 
Functional roles of IDRs 
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 IDRs are now recognized as a functional unit apart from structured domains (1, 2) 
(Figure 1.1C). Several proteome-wide datasets revealed that “hub” proteins that interact 
with multiple partners tend to encode IDRs (3, 4). Because IDRs are inherently flexible, 
they can adopt various conformations that fit many targets, allowing IDRs to mediate the 
functions of proteins orchestrating complex cellular signaling pathways (5–7). For example, 
calmodulin has a central disordered region that interacts with over thirty proteins in 
response to increased cellular Ca2+ levels, enabling calcium-based cellular responses such 
as glycogen breakdown and smooth muscle contraction (Figure 1.1A) (3, 8, 9). Also, the 
CREB-binding protein, a transcriptional coactivator, is comprised of long IDRs connecting 
globular domains and interacts with hundreds of partners, which allows the gene regulation 
of processes as diverse as embryonic development and hypoxic response (10–12). A central 
feature of these IDRs is the presence of molecular recognition features that enable binding 
to many partners, facilitating the regulatory complexity of eukaryotic systems (2, 13).  
 Recent studies have established that in eukaryotic cells, IDRs with a low-
complexity sequence can form micron-scale compartments that lack surrounding 
membranes (14–16). These structures function to locally concentrate proteins and nucleic 
acids into so-called biomolecular condensates. The condensates are involved in diverse 
cellular processes, including ribosome biogenesis, DNA damage, meiotic cell division, and 
stress resistance (15, 17–20). The assembling principle for such compartment has been 
described as liquid-liquid phase separation by which biomolecules are separated into a 
dense phase from a diluted phase in solution (14, 15). These IDRs are enriched with 
multivalent elements that govern intra- or inter-molecular interactions, providing the 
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propensity to naturally assemble into liquid-like droplets in solution or membraneless 
organelles in cells (16, 21, 22).   
 IDRs also perform additional regulatory roles through multiple mechanisms. First, 
IDRs can modulate an activity of other parts within the same protein through allosteric 
modulation or competitive binding. For example, a C-terminal IDR of glutamate receptor 
illustrates that zinc binding to the IDR induces allosteric inhibition of channel gating (23). 
In the case of HMGB1, the IDR inhibits DNA binding activity by occluding the basic DNA 
binding surfaces, preventing it from regulating gene expression (24). Secondly, IDRs are 
frequently subjected to post-translational modifications (PTM) that changes the stability or 
functional states of a protein as seen in histone tails or in cytoplasmic tails of receptor 
tyrosine kinase (2, 25–27).  
  
 IDRs have also been identified in a variety of DNA-binding proteins (28–33). Here, 
IDRs engage in diverse pathways mostly by adjusting target binding or post-translational 
modifications. For example, the CtIP/Sae2 family of DNA double-strand break repair 
proteins has IDRs that are required for bridging two DNA strands and interacting with 
other key proteins in the pathway (28). IDRs in single-strand binding proteins regulate 
cooperative binding on ssDNA (34). IDRs in histone chaperones contribute to chromatin 
remodeling by regulating their dynamic binding to histones and re-positioning 
nucleosomes through post-translational modifications (29). Moreover, phosphorylation of 
IDRs in transcription factor Ets1 reduces the DNA binding affinity (35). 
 Although many studies have uncovered IDRs that modulate binding activity for 
DNA or target proteins, how such IDRs play a role in the dynamic behavior of DNA-
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binding proteins on chromatin is poorly explored. In this thesis, I investigate how IDRs 
impact the dynamic behavior and enzymatic functions of DNA-binding proteins in the 
context of chromatin. 
 
Chromatin 
 Chromatin is a complex of genetic material composed of DNA and proteins 
required for the compaction of the nearly two-meter long human genome into the ~10 µm-
diameter nucleus. The fundamental packaging unit of chromatin is the nucleosome: 147 
base-pairs (bps) of DNA wrapped around a histone octamer that is comprised of two copies 
of each of the core histones – H2A, H2B, H3, and H4. In higher eukaryotes, there is an 
additional histone called H1 that further condenses the histone-DNA complex. Wrapping 
DNA around histone octamers ultimately leads to a ~10,000-fold condensed DNA structure, 
which is referred to as chromatin. Nucleosomes were first visualized as spherical 
complexes connected by DNA filaments (“beads-on-a-string”) via electron microscopy (36) 
(Figure 1.2A). Further studies highlighted the importance of nucleosome occupancy in 
determining cell fate, DNA replication and repair, global gene expression patterns, and 
tumorigenesis (37–40). Our understanding of how the regulation of such chromatin-
binding proteins leads to such cellular defects is an active area of modern research.  
 
Rationale for efficient target search of chromatin-binding proteins 
 DNA replication, DNA repair, and gene transcription all initiate at a specific 
sequence or region that must be targeted by proteins. During the target search, such a 
protein is faced with thermodynamic and kinetic challenges (41): The thermodynamic 
	
5	
challenge means that a protein should recognize and tightly bind the target site among the 
106 - 109 bp non-specific sites with single bp precision (41). The kinetic challenge refers 
to finding a target in mere seconds amidst the crowded chromatin occupied by nucleosomes 
and other protein machinery. Because the cellular processes are controlled through a 
protein signaling pathway, incorrect or untimely binding on chromatin can disrupt 
functional DNA repair or gene expression. Thus, efficient target search by chromatin-
binding protein is necessary to avoid serious problems in cells. 
 
Facilitated one-dimensional diffusion of chromatin-binding proteins 
 Rapid search for a specific chromatin site by proteins can be achieved by two non- 
mutually-exclusive pathways: one-dimensional (1D) diffusion along a DNA (sliding), and 
three-dimensional (3D) diffusion (42). A protein that binds DNA through 3D diffusion can 
perform a round of 1D search along the DNA molecule and vice versa. Experimental 
evidence of 1D diffusion was first provided by measuring the kinetics of lac repressor-
operator interaction using filter binding assays (43). Following studies have revealed that 
the rate of specific binding to a target site was significantly increased by lengthening 
nonspecific DNA surrounding the site (41, 42, 44, 45). An in vivo single-molecule study 
has revealed that a LacI repressor spends ~90% of the time as nonspecifically bound to and 
diffusing on DNA during the target search for its operator (46). Furthermore, single-
molecule techniques have directly shown that numerous proteins’ target search on DNA is 
facilitated by 1D diffusion on DNA (47–49). Examples include the T7 RNA polymerase, 
Type III restriction enzyme EcoPI, and mismatch repair proteins such as Msh2-6, Msh2-3, 
and Mlh1-Pms1 (49–52).  
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 1D movement by proteins on DNA has been subdivided into two distinct 
mechanisms: 1D sliding and hopping (Figure 1.2B) (53). 1D sliding is a diffusion mode 
that follows the helical patch of the DNA backbone without complete dissociation. This 
mode is useful for a protein that needs to recognize a subtle difference in the DNA 
backbone (50, 51). Hopping refers to a series of microscopic dissociation and association 
of proteins: a model where non-specifically bound proteins dissociate from the DNA and 
then rapidly reassociate with the same or nearby DNA site. Notably, hopping is 
advantageous in that it can i) move to another proximal DNA strand without undergoing 
3D diffusion, and ii) enable the bypass of obstacles on chromatin as it diffuses on DNA.  
 If a protein loses its target search capability entirely or has it replaced by a different 
one, it may become non-functional (50, 54). For example, Msh2-6 and Msh2-3, the lesion 
sensor proteins in DNA mismatch repair, each possess a mispair-binding domain (MBD) 
that confers a different target search mechanism. When the MBD of Msh3 was replaced 
with that of Msh6, Msh2-3 lost its hopping mechanism as well as its nucleosome bypass 




DNA Mismatch Repair 
 
Significance of DNA mismatch repair 
 Accurate and synchronized replication of DNA is required for proper cell division. 
Errors during DNA replication cause heritable mutations that may be deleterious for the 
fitness of progeny. However, the replication machinery introduces an incorrect nucleotide 
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every ~107 nucleotides per cell cycle (55). Therefore, the diploid human genome will 
accumulate ~600 replication errors during replication of its ~6 billion nucleotides (55). The 
spectrum of replication errors ranges from single base-pair mismatches (SBMs; the base 
pairing with non-complementary bases) and short insertion/deletion loops (IDLs; 
protruded non-complementary single-stranded DNA) (56, 57). Cells have evolved a post-
replicative mismatch repair (MMR) system to correct these errors (Figure 1.3). The MMR 
system increases the replication accuracy by 100-fold (58).  
 MMR is evolutionarily conserved and proteins capable of executing MMR are 
found in all kingdoms of life. Defects in MMR factors cause hypermutations in E. coli. In 
humans, defects in MMR proteins are the main cause of Lynch syndrome, which increases 
the risk of colon cancer as well as endometrial, ovary, stomach, small intestine, brain, and 
skin cancers (59, 60). Thus, functional MMR activity is required for maintaining genome 
integrity and to prevent human diseases. 
 MMR is also implicated in trinucleotide repeat (TNR) instability. An increased 
number of the repeats causes many neurological disorders (61). For example, Huntington’s 
disease is caused by the expansion of (CAG)n repeats in the htt gene (62, 63). These repeats 
can form extrahelical DNA structures (Figure 1.6) and these structures tend to expand in 
affected tissues presumably due to aberrant DNA repair (64). To date, MMR seems to both 
potentiate and attenuate TNR-mediated instability (65, 66). Studies using an in vitro cell 
extract system have shown that MMR proteins can repair the TNR-driven hairpins on non-
replicating DNA (64, 67). On the other hand, genetic studies have revealed that deletions 
of key MMR proteins resulted in dramatic reduction of TNR expansions in mammalian 
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cells (68–71). Intensive research on the relationship between MMR proteins and TNR 
instability are needed to understand why the normal repeat sequences become 
pathogenically long and how both normal and expanded TNRs are handled by the MMR 
system. 
 
Overview of MMR mechanism 
 All prokaryotic and eukaryotic MMR share similar biochemical steps. MutS and its 
eukaryotic homologs act as lesion sensors. MutS homologs recognize various types of 
replication errors by sensing non-B-form and bent DNA (72). Then, MMR-specific 
endonucleases, MutL homologs or MutH in E. coli, excise the lesion-containing DNA 
strand. This excision step should occur on the specific DNA strand that contains a lesion, 
or the error will be transmitted during next DNA replication. Strand discrimination is 
achieved by the presence of methylation at a specific sequence GATC in E. coli, and by 
the orientation of PCNA in eukaryotes (73, 74). Next, the lesion-containing DNA is 
degraded by exonucleases, and DNA is resynthesized by PolIII in E. coli. and Polδ or Polε 
in eukaryotes (Figure 1.3). In this thesis, I will focus on eukaryotic MMR.  
 Eukaryotes have two lesion sensors that form heterodimers, Msh2-Msh6 (MutSα) 
and Msh2-Msh3 (MutSβ). They have distinct mispair-binding domains that tend to target 
different subsets of lesions, but also share some target overlap. Msh2-6 recognizes single 
base-pair mismatches (SBM) and 1 nt short insertion/deletion loops (IDL) whereas Msh2-
3 recognizes larger IDLs (up to 15 nt) and some SBMs (75, 76). Msh complexes form a 
sliding clamp with ATP and are able to diffuse on DNA, but each complex has different 
target search mechanisms (50). Whereas Msh2-6 uses 1D sliding, Msh2-3 uses a hopping 
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mechanism that also allowed the protein to bypass nucleosome barriers to efficiently target 
a lesion on chromatin (50). Once the lesions are recognized by Msh complexes, 
endonucleases are recruited to excise the lesion-containing strand. 
 Mlh1-Pms1 (Mlh1-Pms2 in humans) is an endonuclease in eukaryotic MMR (77). 
This heterodimer complex is recruited to an MMR site after lesion recognition by Msh2-6 
(78). The endonuclease activity of Mlh1-Pms1 requires PCNA loading by RFC on DNA. 
Mlh1-Pms1 is dispensable when a nick is present 5’ to a mismatch, (79) but the presence 
of Mlh1-Pms1 increases the rate of MMR (80). A recent single-molecule study has shown 
the 1D diffusion of Mlh1-Pms1 on DNA (81). How the diffusing activity of Mlh1-Pms1 is 
connected to its multiple nicking activity is explored further in this thesis.  
 ExoI is a 5’ to 3’ exonuclease and can degrade DNA from a DNA end or a nick 
(82). ExoI is recruited to repair sites via interactions with Msh proteins and Mlh1 (83). 
ExoI is not strictly required in vivo as ExoI-null cells are MMR-proficient with only 2-4 
fold increase in mutation rate (79, 84). Genetic analyses in yeast have revealed the 
existence of ExoI-dependent and ExoI-independent subpathways in MMR (79). The 
majority of mutations affecting ExoI-independent MMR cause defects in efficient Mlh1-
Pms1 endonuclease. The interaction of ExoI with Mlh1-Pms1 was required in the ExoI-
dependent MMR. (85, 86). It is clear that Mlh1-Pms1 functions are important in both MMR 
pathways to degrade the lesion-containing DNA strand. To complete the repair, DNA 
polymerase δ resynthesizes the DNA gaps made during nucleolytic degradation by Mlh1-
Pms1 and ExoI, and the resulting nicks are sealed by DNA ligase (79). 
 
Structure and Function of Mlh1-Pms1 
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 Mlh1-Pms1 forms a ring-like structure comprised of long linker arms connecting 
N- and C- terminal domains (Figure 1.4). The N-terminal domains (NTDs) of Mlh1-Pms1 
are highly conserved in sequence and possess ATP-binding capabilities (87, 88). Mutations 
in the NTD of human Mlh1-Pms2 has been associated with cancer predisposition and failed 
in mismatch correction in vitro (89–92). The ATPase of Mlh1-Pms1 has been classified 
into the GHKL family because the ATPase domains of DNA Gyrase, Hsp90, histidine 
Kinase, and MutL display similar features that are distinct from canonical ATP-binding 
folds such as Walker-type ATPases (88, 93). These proteins exist as dimers, and the 
ATPase domains self-associate upon ATP binding, forming an ATP-induced central cavity 
which helps to capture a DNA substrate (Figure 1.5). ATP hydrolysis does not directly 
power this ATPase domain dimerization (87, 88, 93). Studies using prokaryotic MutL have 
suggested that ATP induces local structural rearrangement around the ATP binding site, 
which results in NTD dimerization and causing the CTD and NTD to be in close proximity 
(87, 94, 95). Using limited proteolysis and yeast two-hybrid assays, P. Tran et. al. have 
shown that the NTD of yeast Mlh1, but not the CTD, undergoes a conformational change 
triggered by ATP, making NTD of Mlh1-Pms1 heterodimerize (92). Similar properties of 
ATP-induced conformational change have been observed in hMutLα (91, 96). AFM 
imaging directly showed that yeast Mlh1-Pms1 is mostly present in an ‘open’ extended 
form in the apo (no nucleotide) state, and transitions to the ‘closed’ form upon nucleotide 
binding (97). Aside from the “gate” formed by ATP-induced dimerization for DNA capture, 
the positive charges on the NTD are also thought to provide a groove for DNA binding via 
electrostatic interactions (98–100). Mlh1-Pms1 can bind both ds- and ss-DNA with higher 
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affinity for dsDNA, and its cooperative binding to DNA has been observed using AFM, 
marked by long track formation of the protein on dsDNA (98, 100, 101).  
 The CTD of Pms1 in yeast (Pms2 in human) has a conserved DQHA(X)2E(X4)E 
endonuclease motif (77, 102, 103). Point mutations within the motif of yeast Mlh1-Pms1 
greatly increased mutation rates in vivo, and a missense mutation in the motif of hPms2 has 
been found in a family with Turcot syndrome (77, 104). Several studies have shown that 
B. subtilis MutL, A. aeolicus MutL (aqMutL), yeast and human MutLα, but not E. coli 
MutL, are Mn2+–dependent endonucleases that are stimulated by ATP (77, 102, 103, 105, 
106). The CTD from aqMutL and yeast Mlh1-Pms1 have shown very weak endonuclease 
activity compared to a full-length protein containing the NTD (103, 105, 106). However, 
the endonuclease-dead yeast Mlh1-Pms1 mutant did not affect ATPase activity or 
formation of a complex with mismatch-bound yeast Msh2-6 (77). These observations 
suggest that conformational rearrangements of Mlh1-Pms1 must occur in the presence of 
both NTD ATPase and the CTD to facilitate nicking activity (77, 102, 103).  
 Mlh1-Pms1 has linkers between the ATPase and dimerization domains. The linker 
arms seem to lack secondary structure based on circular dichroism spectroscopy and AFM 
imaging, which is consistent with the secondary structure prediction using PONDR a web-
based predictor of IDRs (107). These linkers share no sequence similarity among MutL 
homologs (97, 108) (Figure 1.4). E. coli MutL has a proline-rich 100-residue linker that 
tolerates sequence substitutions; deleting up to one-third of its length did not reduce MMR 
activity (108). PONDR predicts that S. cerevisiae Mlh1 and Pms1 have 160-residue and 
290-residue linkers, respectively (Figure 3.1). In addition to larger linker arms than MutL, 
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Mlh1-Pms1 possesses a nucleolytic function that is not present in E. coli MutL. Consistent 
with these observations, deletions of only one-sixth of each linker compromised MMR in 
S. cerevisiae (109). However, why the disordered linkers of Mlh1-Pms1 are essential for 
functional MMR in vivo is not known. Chapter 3 of this thesis investigates the mechanistic 
roles of the disordered linkers in Mlh1-Pms1.  
 
Intrinsically Disordered Regions in Transcription  
 
IDRs in transcriptional regulators 
 Computational analysis of datasets for transcription factors (TF) retrieved from 
Swiss-Prot indicates that > 90% of these TFs possess IDRs (110). This tendency was more 
prominent in eukaryotic TFs than in prokaryotes, reflecting the heightened complexity in 
eukaryotic gene regulation (110). Several studies have established that disordered regions 
of transcriptional coactivators CREB-binding proteins and p300 take up nearly 60% of the 
sequence and are indispensable for their ability to interact with hundreds of TFs to regulate 
numerous cellular signaling pathways (12, 111). IDRs in other TFs including ETS factors 
are important for tuning DNA binding affinity, allowing for precise regulation of ETS-
mediated transcriptional activity (31, 32). Furthermore, a recent study has claimed that 
coactivators BRD4 and MED1 are concentrated through IDRs and forms a transcription 
apparatus at super-enhancer regions in vivo (112).   
 
Gene controls in cell identity and disease 
 Enhancers are DNA regions that are bound by transcription factors (TFs) to activate 
gene expression and are approximately one to several hundred base-pairs in length (113). 
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Super-enhancers (SE) are clusters of enhancers that drive the robust expression of genes 
controlling cell fate specification during various cellular processes including embryonic 
development (114–116). Enhancers in SEs possess unusually high occupancy of enhancer-
associated factors such as Mediator and p300. They also have higher levels of acetylation 
of histone H3 lysine 27 and other enhancer-associated histone marks than regular 
enhancers. Since SEs were initially described in murine cell identity genes (114), it has 
been suggested that SEs play key roles in human cell identity and diseases by detecting 
histone H3K27ac modification as a SE marker (116). Indeed, most SEs in humans activate 
cell type-specific genes, and the vast majority of disease-associated SNPs (such as those 
involved in diabetes and Alzheimer’s disease) and oncogenes are associated with SEs (116). 
However, no previous group has shown whether a human pathogen uses SEs to maximize 
virulence, transmissibility, or other aspects of pathogenicity. 
 
A case study of IDR-containing TFs relevant to cell identity in a human pathogen 
 Candida albicans is a pathogenic yeast that is present in the human intestinal tract 
and mouth. It is normally commensal and harmless as a major member of human 
microbiome but can be infectious in severely immunocompromised patients (117). This 
fungal pathogen can reversibly switch between two cell types named “white” and “opaque”, 
and each type is heritable (118). These two cell types display distinct properties in 
metabolic preferences and mating competence as well as cell structures despite their 
identical genetic sequences (119). This suggests that the cell type switching is regulated 
epigenetically. Several studies established that the white-opaque switching is controlled by 
a transcriptional network comprising at least six master TFs including Efg1, Wor1, Wor3, 
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Wor4, Czf1, and Ahr1 (120–122). I propose that the TF network in cell type switching in 
C. albicans likely co-occupies a SE for several reasons: i) SEs are known to control cell 
identity, ii) ChIP analysis showed that the target genes in the network are bound by multiple 
TFs even though each TF paradoxically has its own DNA binding motif (122), and iii) the 
TFs directly activate or repress other TFs in the network (forming both positive and 
negative feedback loops) in a way that is associated with the timing of white-opaque 
transition. Although the cell type is not directly correlated to pathogenicity, it is clear that 
the TF that is controlling the cell type switching is also responsible for the virulence of this 
species (123, 124).  
 Strikingly, the master TFs in the white-opaque circuit contain large disordered 
regions (See Chapter 5). I hypothesize that the disordered regions are the key identities by 
which the TFs in this cell type switching create a super-enhancer that is a concentrated 
transcriptional apparatus to regulate a set of genes for a cell type. In Chapter 5, I show and 






Figure 1.1: Overview of IDRs in proteins. (A) Presentation of disordered and structured 
regions in two cases: a transcription coactivator CBP (10) and calcineurin (125). (PDB 
2KA6 and PDB 5C1V). Representative IDRs and structured parts are indicated in blue and 
black arrows, respectively. (B) Predicted disordered residues by VSL2 in three domains of 
life (126). IDRs tend to increase with increasing complexity, comprising more than 30% 







Figure 1.2: Chromatin and target search mechanisms of chromatin-binding 
proteins. (A) Schematic representation of chromatin. DNA is assembled with 
nucleosomes, which forms ‘beads-on-a-string’. Adapted from Ref. (127). (B) Schematic 
of target search mechanisms of proteins on chromatin. Many DNA-binding proteins can 
interact with chromatin at random sites via 3D diffusion from non-chromatin areas. Once 
a protein bind DNA, it can slide along the helical track of DNA (1D sliding), or it can 







Figure 1.3: Two models of eukaryotic DNA mismatch repair. The major MMR 
proteins sequentially act on DNA region that misincorporated a mismatched base during 
DNA replication. First, Msh2-Msh6 recognize a mismatch through 3D and 1D diffusion 
in the vicinity of replication fork. Mismatch-bound Msh2-6 recruits multiple Mlh1-Pms1. 
The endonuclease Mlh1-Pms1 is activated by PCNA to produce nicks on DNA. PCNA 
also serve as a sensor for strand discrimination. In ExoI-dependent model, Exo1 enters 
through the nicks for further degradation on the lesion-containing strand. In ExoI-
independent pathway, Mlh1-Pms1 stimulated by PCNA performs multiples rounds of 
nicking resulting in DNA degradation past the mispair (79). The gaps are filled by Polδ 









Figure 1.4: Structure of Mlh1-Pms1 and prediction of IDR linkers in MutL 
homologs. (A) Domain structure of yeast Mlh1-Pms1 (99, 103). N-terminal regions are 
ATPase in both subunits. C-terminal domains have dimerization interfaces for interacting 
each other (green). Mlh1 CTD has binding site for ExoI (pink), and Pms1 CTD has the 
endonuclease site (red). (B) Illustration of Mlh1-Pms1 structure based on structural and 
biochemical data (88, 99, 103). N-terminal domains have ATP binding motifs, C-terminal 
domain of Pms1 has an endonuclease motif. The N- and C- terminal domains are 
connected by long flexible linkers, and the two subunits dimerize through C-terminal 
domains. (C) IDR prediction analysis of the MutL (E. coli), Mlh1 (yeast and human), and 
(D) Pms1 (yeast) and PMS2 (human) using PONDR (107). All three species have long 







Figure 1.5: ATP-induced conformational change of Mlh1-Pms1. Illustration of 
conformational change by ATPase cycle of Mlh1-Pms1 based on structural and 
biochemical data. In the absence of ATP, the complex is present as open, extended form. 
ATP binding to Mlh1-Pms1 induces dimerization of N-terminal domains and compaction 







Figure 1.6: Hypothetical model of trinucleotide repeat (TNR) instability. (A) TNR 
instability caused by DNA polymerase slippage (61). (B) Hypothetical model of PCNA 
loading on TNR and thus MutLα–dependent nicking (130). As well as ssDNA/dsDNA 
junction, RFC can load PCNA onto non-complementary nucleotides such as TNR-driven 
stem-loop structures, which can recruit Mlh1-Pms1 to introduce nicks near the 









Figure 1.7: Phase-separation (LLPS) model for biomolecular condensates. (A) 
Biomolecules with multivalency start condensing and phase separate in a concentration 
manner. The phase-separated condensates are found as liquid droplets in vitro and 
membraneless organelles in a cell. The components within the membraneless organelles 
are dynamic and can be exchangeable with exterior environment. (B) Schematic 
representation of the phase-separation model for transcriptional control. Transcription 
factors and mediators can form the multi-molecular complex of transcriptional regulators 






Chapter 2.  Reconstitution of Human Nucleosomes on DNA Curtains 
 
Parts of this chapter have been published in the following journal: 
 
Brown,M.W., Kim,Y., Williams,G.M., Huck,J.D., Surtees,J.A. and Finkelstein,I.J. (2016) 
Dynamic DNA binding licenses a repair factor to bypass roadblocks in search of DNA 
lesions. Nature Communications., 7, 10607 
– Y.K. purified human histones, reconstituted nucleosomes, and characterized 




Because DNA mostly exists as chromatin in eukaryotes, it is important to study DNA-
related processes in the context of nucleosomes as well as on naked DNA. Therefore, 
several ways to reconstruct nucleosomal DNA substrates have been developed (131–133). 
Using these reconstituted nucleosomes for in vitro studies is useful because (i) they can be 
prepared with well-defined components of purified histones and DNA, and (ii) binding of 
proteins to nucleosomes or distinct species of nucleosomes can be easily detected by a non-
denaturing gel-shift assay. There are two methods that have been widely used for 
nucleosome reconstitution: ATP-dependent assembly, which uses ATP-fueled enzymes, 
and ATP-independent assembly via step-wise salt dialysis (132–134). Both approaches 
require purified core histones and DNA to be assembled, but additional factors, ATP-
utilizing protein CAF-1 and histone chaperon Nap-1 are required for the ATP-dependent 
assembly (131). Although enzyme-dependent nucleosome assembly is a good way to 
obtain periodic nucleosome arrays that are closer to physiological conditions, the salt 
dialysis approach has several advantages: (i) it requires only core histones and DNA, and 
(ii) the density of nucleosomes on DNA can be easily modified with changing 
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DNA:octamer ratio. The step dialysis method is achieved by gradually decreasing the salt 
concentration of a solution of the octamer and DNA from 2M to 0.2M NaCl (135). Protein 
interactions within a histone octamer are dominated by hydrophobic interaction and the 
histones form a stable octamer complex in high salt(136, 137). Upon lowering salt 
concentration from 2M to 1M NaCl, histone octamers start dissociating to (H3-H4)2 
tetramers and H2A-H2B dimers. At around 1M NaCl, tetramers stably bind DNA, whereas 
the dimers do not at this point. When the salt is further decreased to 0.6M NaCl, the dimers 
cap the tetramer-DNA complex to complete octamer formation(138). Since the gradient 
dialysis strategy form relatively irregular nucleosome arrays on DNA compared to the 
enzyme-dependent method, tandem repeats of nucleosome positioning sequence (NPS) 
have been used to obtain nucleosome arrays positioned at defined sequences on DNA. The 
commonly used NPS includes the sea urchin 5S rRNA gene that has been found in nature, 
or a synthetic sequence called “601” with high affinity for nucleosome formation(139, 140). 
This strategy facilitated the use of salt dialysis method for reconstitution of nucleosome 
arrays in studying DNA-binding proteins on nucleosomal DNA(37, 141).  
 How chromatin-binding proteins deal with the nucleosome obstacles and find their 
particular target sequences or binding partners is an important question to address. To 
answer this fundamental question, I developed a method to reconstitute fluorescent human 
nucleosomes on DNA and visualize these complexes using the DNA curtains assay. I 
characterized the reconstituted human nucleosomes via biochemical and single-molecule 
DNA curtains assays. I also confirmed that the DNA binding distribution of human 
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nucleosomes on a 48kb DNA substrate is statistically indistinguishable from previous 
results of Saccharomyces cerevisiae nucleosomes.  
 
Materials and Methods 
 
Purification of wild type and recombinant hH2A 
The wild type or 3xFLAG H2A plasmid was transformed into BL21(DE3) codon 
plus RIL cells (Agilent). A colony was inoculated into 50 mL LB with 50 µg mL-1 
carbenicillin and 34 µg mL-1 chloramphenicol, and grown at 37°C overnight. Fifteen 
milliliters of the overnight culture were seeded into 1.5 L LB and grown in the presence of 
both antibiotics. When the culture reached an OD600 of 0.6, 0.2 mM IPTG was added and 
the induction continued at 37°C for 3.5 hours. Cells were harvested at 5000 g for 15 
minutes, and resuspended in 150 mL lysis buffer (100 mM NaPO4 pH 8.0, 8 M urea, 10 
mM DTT, 15 mg benzamidine). Urea was deionized (501-X8 resin, Bio-Rad) immediately 
before use. Cells were lysed by sonication on ice, and centrifuged at 12°C and 100,000 g 
for 30 minutes. A 100 mL column was packed with 25 mL of SP-Sepharose Fast Flow 
resin (GE Healthcare), washed with 10 column volumes (CV) of water, and equilibrated 
with 10 CV of wash buffer (100 mM NaPO4 pH 8.0, 7 M urea, 10 mM DTT, 0.3mM 
benzamidine). The 150 mL supernatant was added to the column and rotated for 1 hour at 
RT. The supernatant was washed with 5 CV of wash buffer, and eluted with five fractions 
of 5 mL elution buffer (100 mM NaPO4, pH 8.0, 1M NaCl, 7 M urea, 10 mM DTT, 4mM 
benzamidine). The resulting 25 mL eluent was loaded onto a Superdex-200 column (GE 
Healthcare) equilibrated in SAU-100 buffer (20 mM NaAcetate pH 5.2, 7 M urea, 100 mM 
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NaCl, 1 mM EDTA, 5 mM β-mercaptoethanol). Gel filtration was performed using 120 
mL SAU-100 buffer and the histone-containing fractions were loaded onto a tandem Q/SP 
column (10mL each). After loading the histones, the tandem column was washed with 5 
CV of SAU-100. The Q column was removed and 3xFLAG H2A was eluted with a gradient 
from 0% to 100% SAU-600 (20 mM NaAcetate pH 5.2, 7 M urea, 600 mM NaCl, 1 mM 
EDTA, 5 mM β-mercaptoethanol) over 20 CV. The eluate was fractionated in 1.2 mL 
fractions and the histone-containing fractions were confirmed by SDS-PAGE. The protein 
concentration was determined by running SDS-PAGE gel with BSA standards (Pierce 
Biotechnologies). Purified protein was lyophilized and stored in -80°C. Both wild type and 
3xFLAG H2A proteins purified with similar elution profiles and final yields. 
 
Purification of H2B, H3, H4 
Each of the three histones was purified from inclusion bodies as previously 
described, with minor modifications(132). Briefly, each histone was overexpressed in 
BL21(DE3) codon plus RIL cells. Cells were grown at 37°C and 0.2 mM IPTG was added 
at OD600 = 0.6, followed by additional 3 hours of induction at 37°C. Cells were harvested 
by centrifugation at 5000 g for 20 min at room temperature. Cell pellets were suspended in 
25 mL TW buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM EDTA), and stored at -
80°C until use. Each pellet was thawed and diluted up to 35 mL total volume using TW2 
buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM EDTA, 5 mM β-mercaptoethanol, 
1 mM benzamidine, and 1% (w/v) Triton X-100). Cells were lysed by sonication on ice for 
2 min (10s on – 50s off). To harvest the inclusion bodies, the lysate was centrifuged at 
20,000 g for 20 minutes at 4°C. The pellets were rinsed with TW2 buffer by resuspending, 
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and centrifuged at 20,000g for 20 minutes at 4°C. The pellet was washed in same way twice 
using TW2 without Triton X-100, and the final pellet was stored at -80°C. 
 Each inclusion body pellet was mixed with 200 µL DMSO and 6.5 mL unfolding 
buffer (20 mM Tris–HCl, pH 7.5, 7 M guanidinium-HCl, and 10 mM DTT) by gently 
agitating for 1 hour at RT, and centrifuged at 20,000 g for 20 minutes at 4°C. This was 
repeated two more times, and the supernatant from each centrifugation was dialyzed 
against 1L urea buffer (10 mM Tris–HCl, pH 8.0, 7 M urea, 1 mM EDTA, 5 mM β-
mercaptoethanol, and 100 mM NaCl for H2B, 200 mM NaCl for H3 and H4) using 3,500 
or 7,000 MWCO dialysis tubing (SnakeSkin, Pierce Biotechnologies). A tandem Q/SP 
column was equilibrated with 10% buffer B (10 mM Tris–HCl, pH 8.0, 7 M urea, 1 mM 
EDTA, 1 mM DTT, 1 M NaCl; buffer A is same components without 1 M NaCl), and the 
dialyzed histones were loaded and washed with 10% buffer B. H2B was eluted from 10% 
to 40% buffer B over 20 CV in 200 minutes and H3 and H4 were eluted from 20% to 50% 
buffer B over 20CV. The purified histones were checked by SDS-PAGE, lyophilized, and 
stored at -20°C until use. 
 
Histone octamer assembly 
Each of the four histones was dissolved in unfolding buffer (20 mM Tris–HCl pH 
7.5, 7 M guanidinium-HCl, and 10 mM DTT), and gently agitated for 1 hour at RT. Each 
histone was mixed in equimolar ratios (used 10% higher molar ratio for H2A/H2B relative 
to H3/H4), and adjusted to a final concentration of 1mg/mL. The mixture was dialyzed 
against refolding buffer (10mM Tris-HCl pH 8.0, 1mM EDTA, 5mM β-mercaptoethanol, 
2M NaCl) using 3,500 MWCO dialysis tubing with several buffer exchanges over 48 hours. 
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The dialyzed mixture was centrifuged to remove aggregates, and concentrated using spin-
concentrator (Amicon Ultra-15; Millipore) to make a final volume of about 1mL. Gel 
filtration over a (Superdex-200, GE Healthcare) using SAU-200 was performed to resolve 
histone octamers from dimers and tetramers in the refolding buffer. The octamer peak 
fractions were combined, concentrated using a 10,000 MWCO spin-concentrator (Amicon 
Ultra-4, Millipore), and flash frozen using liquid N2. The resulting histone octamers were 
stored in -80°C until use.  
 
Total Internal Reflection Fluorescence (TIRF) Microscopy 
The inverted type Nikon Eclipse Ti microscope was built with homemade aligning 
optic system for our single-molecule study. A 488nm 200mW diode-pumped solid-state 
laser (Coherent) was used for excitation light source, and the beam was aligned to target a 
quartz prism placed on top of a flowcell with a thin layer of immersion oil (Figure 2.1). 
The beam power at the face of the prism was typically ~10mW. Fluorescent images from 
each green and red channel were detected with two EM-CCD detectors at 5.0Hz using a 
200ms exposure time. The data collected from each channel were saved as 8-bit TIFF files 
respectively using NIS-Elements software (Nikon). TIRFM images were collected using a 
60x water immersion objective lens (Nikon, 1.2 NA Plan Apo). 
 
Nanofabrication and flowcells 
Diffusion barriers were constructed on quartz wafer by UV photolithography. The 
100 mm wafer was cleaned with Piranha solution and rinsed with deionized water three 
times. The cleaned substrate was treated with the HMDS (hexamethyldisilizane) at 150°C 
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in a vacuum chamber in order to promote photoresist (PR) adhesion. On the primer-treated 
surface, the positive photoresist AZ5209E was used for spin-coat at 4000rpm for 2 minutes. 
Patterns were written by UV lithography with exposure time of 7.0 seconds using a Cr 
mask and Suss Microtec MA6/BA6 Contact Aligner. After patterning, the resist was 
developed using AZ-726-MIF developer, followed by rinsing with deionized water. The 
substrate was then cleaned with O2 plasma for 1 minute using March Asher. A thin layer 
of chromium was deposited using a Cooke E-beam evaporator, followed by lift-off using 
acetone for 30 minutes with sonication. The patterned wafer was then rinsed with 
isopropanol and dried with N2, and cut into six 55 mm x 22mm slides. To make a flowcell, 
inlet and outlet ports were made by drilling with a drill press (Servo) equipped with a 1.4 
mm diamond-coated drill bit. The slides were cleaned by soaking in 2% (v/v) Hellmanex 
overnight, 1M NaOH, 100% EtOH in order, and stored in 120°C vacuum oven until use. 
The cleaned slide was assembled with a coverslip through double-sided tape (~100µm thick, 
3M). The total volume of the sample chamber was ~15µL.  
 
Lipid bilayer and DNA curtains 
 For the diffusible lipid bilayer surface, lipids were purchased from Avanti Polar 
Lipids and liposomes were prepared as described (142). In brief, a mixture of DOPC (1,2-
dioleoyl-sn-glycero-phosphocholine), 0.5% biotinylated-DPPE (1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-(cap biotinyl)), and 8% mPEG 2000-DOPE (1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine-N- [methoxy(polyethylene glycol)-2000]) 
were used to passivate the chamber surface. mPEG prevents nonspecific adsorption of QDs, 
and biotin-lipid tethers individual DNA substrates. Excess liposomes were removed with 
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buffer containing 10 mM Tris-HCl (pH 8.0) and 100 mM NaCl. The sample chamber was 
then rinsed with buffer A (40 mM Tris-HCl (pH 8.0), 60mM NaCl, 1 mM DTT, 1 mM 
MgCl2, and 0.2 mg ml-1 BSA) for 5 minutes. Streptavidin (0.02 mg ml-1) in buffer A was 
injected into the sample chamber and incubated for 10 minutes. After rinsing with 
additional buffer A, λ-DNA (5~10pM) labeled at one end with biotin was injected into the 
chamber, incubated for 10 minutes, and unbound DNA was removed by flushing with 
buffer A. Application of flow aligned the DNA molecules along the diffusion barriers, 
pushed them into the barriers, and stretched the molecules along the barriers (Figure 2.2). 
 
DNA substrate preparation and DNA staining 
All experiments used lambda DNA (NEB). To immobilize the DNA on the lipid-
bilayer surface, biotinylated oligonucleotides were purchased from IDT. They were 
hybridized to 12-nucleotide overhangs at the end of lambda DNA by slowly cooling with 
thermo cycler after warming to 70°C for 15min. The mixtures were ligated using T4 DNA 
ligase and filtered over Superdex-1000 column to eliminate excess oligomers and other 
reaction components. To visualize DNA backbones, 0.16nM YOYO-1 with oxygen 




Assembling human octamers and gel-based assay 
To fluorescently label the histone octamers for single-molecule imaging, plasmids 
containing wild-type human histones were sub-cloned to include an additional 3xFLAG or 
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a 3xHA (Hemaglutinin) epitope tag. Since the N-terminal tails of histones protrude from 
the nucleosome, the epitope tags have been incorporated into N-terminus of each histone 
(143). Histones were over-expressed in BL21-CodonPlus(DE3)-RIL cells that 
complements eukaryotic tRNA genes lacking in E.coli for their high-level protein 
expression in the T7 expression system. The wild type and recombinant histones were 
successfully over-expressed in E.coli (Figure 2.3A). Histone overexpression in E.coli 
accumulates dense insoluble aggregates called inclusion bodies, which often results from 
partially folded intermediates in vivo (144). Each histone was purified in denaturing buffer 
solution containing 7M urea to help the insoluble histones dissolve from inclusion bodies. 
(132) Several strategies are developed to avoid the formation of inclusion bodies by 
changing culture conditions (e.g., decreasing temperature during protein induction). (145) 
In some cases including histones, however, the inclusion bodies can be useful to collect 
large amount of biologically active proteins by restoring through solubilizing in a strong 
denaturant such as 7M urea followed by dialysis against a refolding buffer solution (146, 
147).   
I followed previous protocol to assemble human histone octamers (132). The four 
histones were combined in denaturing buffer at an equimolar ratio for H3, H4 with 10% 
more for H2A and H2B (Figure 2.3B). It has been reported that H3 and H4 first form the 
tetramer H32-H42, and then two sets of H2A-H2B dimers form the octamer (148, 149). 
Thus, in addition to the canonical octamer, multiple histone complexes can form during 
the reconstitution reaction (149). For this reason, I have filtered the histone mixture over a 
gel filtration column to separate the complexes as well as aggregates. Adding excess H2A 
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and H2B prevents the formation of free H32-H42 tetramers or hexamers, which are hardly 
separated from octamers in the subsequent gel filtration step. In contrast, H2A-H2B dimers 
are easily separated from the octamers (Figure 2.3C) (147). To see whether the octamers 
have been formed and segregated properly, I performed a denaturing SDS-PAGE analysis 
for both wild-type octamers and 3xFlag octamers. The bands of each octamer contained 
each histone showing H2A (or 3xFlag H2A), H2B, H3, and H4 with a 1.0 : 0.9 : 1.2 : 1.1 
stoichiometry as indicated by relative intensities of each band from SDS-PAGE analysis 
(Figure 2.3D). 
I next reconstituted the human octamers into nucleosomes following established 
protocols (132, 147). I reconstituted the histones onto a synthetic 145 bp nucleosome 
positioning sequence labeled “601-DNA” after Widom et. al (140). The “601-DNA” was 
identified through several rounds of selection that comprised of salt dialysis reconstitution, 
sucrose gradient separation, and sequencing of the selected DNA from 5x1012 random 
sequences(140, 150). The affinity of the 601 DNA for nucleosome was determined by 
measuring free energy of 601 DNA relative to that of 5S rRNA gene sequence, which 
showed 2.9kcal/mol (140). Thus, the 601 acts as a strong positioning sequence where 
histone octamers selectively bind, which has been widely used for positioning histone 
octamers at precise DNA locations (151–153). Hence, I chose to use this DNA in testing 
the biochemical properties of our human histone octamers. The PCR-amplified DNA were 
concentrated via concentrator (Zymo Research) and dissolved in 2M TE buffer, then mixed 
with human octamers for stepwise salt dialysis (Figure 2.4A) (132). The reconstituted 
nucleosomes were analyzed via electrophoretic mobility shift assay (EMSA) using a 5% 
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TBE native gel (Figure 2.4B). Wild-type nucleosome showed a single up-shift band and 
did not exhibit any super-shift in the presence of α-Flag antibody (lanes 9 and 10), 
indicating that the α-Flag antibody does not bind any regions of the wild-type human 
octamer. The octamer containing 3xFlag H2A also formed nucleosomes (Figure 2.4B lane 
3). Unlike wild-type nucleosomes, the 3xFlag tagged nucleosomes displayed two distinct 
bands. I hypothesize that the two bands may come from partial proteolytic degradation of 
the epitope tag. It has been reported that N-terminally inserted epitope tags (Flag, HA etc.) 
are susceptible to proteolysis (154). To further prove the hypothesis, mass-spectrometry 
analysis can be performed to detect which residues are eliminated.  
Next, I performed super-shifts with reconstituted nucleosomes and α-Flag 
antibodies. Because each nucleosome has up to six Flag epitopes, I could observe the step-
wise shifted bands of 3xFlag nucleosomes as I increased the antibody concentration (Figure 
2.4B lanes 4-7). The upper band of the two species from 3xFlag nucleosomes first 
disappeared with α-Flag antibody presumably because it is more intact species that has all 
functioning epitope tags. To verify that the epitope tag is providing a unique target for the 
α-Flag antibody, I also tested α-HA antibody at the highest concentration I used in our gel-
shift assays. There was no super-shift band for this condition, which looked similar to the 
no antibody condition (lanes 3 and 8). I also confirmed that the DNA is not recognized by 
the α-Flag antibody (lane 11). I conclude that 3xFlag-H2A containing histone octamers can 
form nucleosomes and that these nucleosomes can be specifically targeted by α-Flag 
antibodies. 
 
Imaging of human nucleosomes on DNA curtains 
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I next reconstituted the human nucleosomes on λ-DNA for our single-molecule 
studies. The experimental procedure for making human nucleosomes on λ-DNA is shown 
in Figure 2.5A. Wild-type λ-DNA is functionalized at one end with biotin for the purpose 
of immobilization to streptavidin surface in the flowcell. After removing all unnecessary 
components using gel filtration column, the functionalized λ-DNA was concentrated via 
isopropanol precipitation, then dissolved in TE buffer containing 2M NaCl to be ready for 
the stepwise salt gradient dialysis step. Human nucleosomes were reconstituted on the 
DNA via step-wise salt gradient dialysis and the DNA was assembled into DNA curtains. 
To fluorescently visualize the human nucleosomes, I conjugated anti-Flag 
antibodies with fluorescent quantum dots (Qdots). Quantum dots (Qdots) are nanometer-
scale (approximately ~10nm in diameter (155)) semiconductor crystals. A core nanocrystal 
made of CdSe is coated with another semiconducting shell such as ZnS, which provides 
better photostability(156). Qdots are superior single-molecule dyes because they are highly 
stable against photobleaching, allowing single-molecule imaging for over twenty minutes 
in our imaging conditions (155, 156). Furthermore, Qdots have narrow emission spectra 
with broad excitation spectra, so we can excite two spectrally-distinct Qdots with a single 
excitation source (e.g., imaging green and red Qdots with a single 488nm laser). This 
enables visualizing of two different proteins simultaneously. Although Qdots have 
excellent optical properties for imaging single-molecules, there are also shortcomings such 
as blinking. The blinking is the process of random switching between ‘on’ and ‘off’ states 
of the Qdot emission. For example, we can observe intermittent blank frames in a movie 
of individual Qdot-protein. This can be problematic for a continuous tracking of protein of 
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interest because we can lose information of its movement that is analyzed based on the 
imaging of particle tracking. This problem can be partially alleviated by adding DTT 
(dithiothreitol) or BME (β-mercaptoethanol) to our buffers (157). For fluorescent labeling, 
I conjugated biotinylated α-Flag antibodies with streptavidin-conjugated Qdots. The 
surface covered with streptavidin was blocked by injecting a buffer solution containing 
free biotins prior to nucleosome labeling. The antibody and streptavidin were pre-incubated 
at equimolar ratio right before use, and then injected into the flowcell to bind and visualize 
the nucleosomes on the DNA curtain (Figure 2.5B). The irregularly deposited Qdot-
nucleosomes were observed on single DNA molecules, as confirmed by the retraction of 
DNA molecules when flow stopped (bottom panel). 
 
Verification of human nucleosomes on 13x601 DNA curtains 
To verify that I have reconstituted authentic nucleosomes and not histone 
aggregates or incomplete histone complexes, I used λ-DNA that incorporated the 13x601 
array at a specific region (Figure 2.6A). The nucleosome-containing 13x601 λ-DNA was 
allowed to make a DNA curtain in the flowcell and was visualized with the biotin-
streptavidin-Qdot strategy. As expected, I could observe a clear line of Qdots positioned at 
around 35kb from starting point of the diffusion barriers (Figure 2.6B). To quantitatively 
determine the position of nucleosomes bound on λ-DNA, I determined the positions of 767 
individual human nucleosomes by measuring the distance in kilobases (kb) from the 
starting point of diffusion barriers. The positioning data was compiled into a histogram to 
which a single Gaussian curve was fit according to equation (1):  
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454             (1) 
where 𝑦 = 	𝑓(𝑥|	𝜇, 𝜎) is the probability density function of a Gaussian distribution at each 
of the values in 𝑥 with mean 𝜇 and standard deviation 𝜎. The center of the peak of the 
curve was located at 34.3kb with a standard deviation of ±2.16, which matches the actual 
region of the 13x601 array comprising 2,330 bp on λ-DNA (Figure 2.6). 
 
Characterization of the human nucleosomes for single-molecule study 
Next, I have characterized the numbers of nucleosomes on single λ-DNA molecules. 
First, I selected a range of the ratios that produce countable numbers of nucleosomes on 
DNA (Figure 2.7). Because Qdots fluoresce intermittently (blinking), I used ten movie 
frames taken over two seconds to detect all of the fluorescent particles. I also selected only 
the particles that were retracted by flow-off in order to eliminate the ones attached to 
surface or the Cr barriers. The number of nucleosomes on each DNA was easily countable 
using a DNA:octamer ratio of 1:75 (Figure 2.7A). Using that ratio, I tested whether the 
nucleosome binding on the DNA follows a Poisson distribution which can be used to 
determine the cooperativity of protein-nucleic acid binding. If a DNA binding protein binds 
DNA in a non-cooperative way, then the distribution of the number of bound protein among 
bulk DNA should obey a Poisson distribution (158). Thus, I asked whether the formation 
of human nucleosomes on λ-DNA displays a Poisson distribution under the low-density 
nucleosome condition. To test this, I made a histogram as a function of number of 
nucleosomes per DNA, and used it to fit Poisson distribution that has the mean and standard 
deviation of the data according to equation (2): 
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    𝑓 𝑥 𝜆 = 	 7
2
8!
	𝑒:7                         (2) 
where 𝑓 𝑥 𝜆  is the probability of a Poisson random variable 𝑥 that represents the number 
of nucleosome binding occurring in a given space (λ-DNA), 0, 1, 2, 3 … and 𝜆  indicates 
the mean number of nucleosome formation on λ-DNA. The result showed that the 
deposition of the nucleosome on DNA fairly well obeyed a Poisson distribution (Figure 
2.7B), which is consistent with a previous observation that binding of histone octamers 
onto DNA is independent of other nucleosome formation(159, 160). In addition, I observed 
a gradual increase in the number of nucleosomes on a single DNA as a function of an 
increasing the DNA:octamer ratio (Figure 2.7C). Above the ratio of 1:75, the nucleosomes 
were so densely packed that it was difficult to count them.  
Having determined that I can deposit nucleosomes on λ-DNA, I asked how our 
positioning distribution of human nucleosomes was affected by DNA sequence. D. Tillo et 
al. showed that GC content is the most influential factor of intrinsic nucleosome occupancy 
in vitro (161). High GC content obviously tends to lack poly-A stretches that are rigid and 
bent, thereby excluding nucleosome formation on the featured sequence. To analyze the 
pattern of positions of human nucleosomes deposited on the DNA curtain, I used the 1:75 
of DNA:octamer condition where approximately 4~6 distinguishable nucleosomes are 
present per DNA. To eliminate the ambiguity of the orientation of the DNA, I consistently 
used the biotinylated oligomers that hybridize to only one side of the DNA. Also, I selected 
the field of views where the DNA molecules are perfectly aligned at the barriers, and only 
the Qdots overlaid on YOYO-stained DNA molecules.  
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To determine the exact position of Qdot-nucleosomes on λ-DNA, each x, y 
coordinate of individual Qdots on DNA was extracted by fitting to a Gaussian curve. The 
coordinate values were subtracted from the position of the barriers to determine the position 
of single Qdot-nucleosome on the DNA. The position data from 2899 particles were 
compiled to a histogram and compared with probability of base contents or yeast 
nucleosome data previously published (162). Next, I produced an A-T or G-C probability 
of λ- DNA, and compared it with our positioning data (Figure 2.8A, top and middle panels). 
The left half of the genome exhibits a high frequency of GC bases. The middle region of 
the DNA around 24 kb has an especially low frequency of GC content, and this region is 
highly matched to lower occupancy in both human and yeast nucleosomes. This is 
consistent with the previous findings that GC content is the major determinant for 
nucleosomes forming on DNA in vitro. I compared the positioning result with yeast data 
(Figure 2.8A, bottom panel). The result indicates that the positioning of human 
nucleosomes is significantly well-correlated with yeast data, showing a Pearson’s r = 0.64 
(Figure 2.8B). Given that our data reproducibility coefficient never exceeds 0.64, it is 
reasonable to argue that the observed positioning pattern of human nucleosomes is 
significantly matched with that of yeast nucleosome. I speculate that the intrinsic variability 
results from the salt dialysis reconstitution that is known as random assembly of 
nucleosomes on DNA, and nucleosome by itself does not possess strong preference for 






The reconstituted human nucleosomes on DNA curtain for single-molecule studies will be 
useful for single-molecule studies and will answer numerous questions with respect to the 
ability of DNA repair enzymes to deal with nucleosome obstacles. For example, yeast 
Mlh1-Pms1 (MutLα) heterodimer has long unstructured linker arms and freely diffuse on 
both naked and nucleosomal DNA (109, 163). Given that MutLα mutants whose linker 
arms are disrupted via TEV protease cleavage showed severe defects in MMR in vivo, it 
can be speculated that the biological role of the linker arm of MutLα is primarily to freely 
navigate whole genome by passing over nucleosomes (109, 163). We can also investigate 
how other MutL homologs such as Mlh1-Mlh3 (MutLγ) manages the nucleosome obstacles 
differently, reflecting the fact that the two homologs act in a distinctive manner in such as 
characteristic of binding to DNA substrate or dependence of other interacting partners(164). 
In addition, there is strong evidence that nucleosomes are controlling the DNA resection 
machineries that generates single-stranded DNA for homologous recombination in double-
stranded break (DSB) DNA repair (165, 166). In conclusion, the development of 
fluorescent nucleosomes for single-molecule studies will allow us to observe detailed 






Figure 2.1: Microscope setup. (A) Schematic of the imaging area using prism Total 
Internal Reflection Fluorescent (TIRF) microscopy. Incoming laser light and a prism are 
used to generate an evanescent field that selectively excites fluorescent molecules close to 
the surface. (B) Light path for prism TIRF Microscope. A 488nm laser was used for 
excitation light source and the beam paths were aligned to target the prism mounted on a 
flowcell. Two EM-CCD (Electron multiplying charge coupled device) cameras were 





Figure 2.2: Experimental layout of making DNA curtain on a lipid bilayer flowcell. 
(A) The images of the patterned chromium diffusion barriers. The top image shows an 
image of at 10x magnification of 6x4 series of barrier sets made of chromium deposited on 
a quartz slide. The bottom image shows a magnified image of a single barrier set with 
annotations. (B) Schematic of the principle of lipid bilayer that permits DNA curtain. The 
slide surface is covered by lipid bilayer containing 0.5% biotin-lipids, allowing streptavidin 
to mediate tethering of biotinylated λ-DNA to the lipid bilayer. As illustrated in the two 
bottom panels, the tethered DNA molecules are driven to the physical barriers when buffer 
flow is applied. (C) Fluorescent images of λ-DNA curtains aligned at the barriers. 
Individual λ-DNA molecules stained by YOYO-1 dye are shown in green. DNA is 
stretched during buffer flow (arrow in left image) and is retracted when buffer flow is 





Figure 2.3: Human histone purification and octamer assembly. (A) Schematic of the 
procedures for histone purification. Each wild-type or epitope-tagged histones was 
expressed in BL21-codon plus RIL cells and purified through gel filtration followed by ion 
exchange. (B) The four histones were mixed at equimolar ratio of H3 and H4 with 10% 
excess H2A and H2B to assemble histone octamers. The mixtures were filtered to eliminate 
aggregates and incompletely assembled octamers. (C) The elution profile of the gel 
filtration chromatography column. Fractions from the octamer peak were pooled and 
further analyzed. (D) A 15% SDS-PAGE analysis of wild-type and recombinant octamers 






Figure 2.4: Human nucleosome reconstitution in vitro and native gel shift assays for 
antibody specificity. (A) A high affinity DNA sequence for histone octamer called “601” 
was used for nucleosome reconstitution. The 145bp 601 DNA was mixed with the human 
histone octamers, and the human nucleosomes were prepared via step-wise salt dialysis. 
(B) 5% TBE native gel assay demonstrates that both wild type and 3xFlag tagged human 
nucleosomes were successfully reconstituted, and the α-Flag antibody specifically binds to 





Figure 2.5: Visualizing human nucleosomes reconstituted on λ-DNA for single-
molecule study. (A) Schematics of the procedures to reconstitute the nucleosomes on λ-
DNA. The λ-DNA was ligated with biotinylated oligomers at one end of the DNA to be 
tethered on flowcell surface. (B) Fluorescent images of human nucleosome deposited on 
λ-DNA. Nucleosomal DNA substrates are anchored to the flowcell surface and aligned 
along the nanofabricated barriers. YOYO-1 stained λ-DNA (green) is extended when 
buffer flow is applied (top panel). Individual human nucleosomes formed on the DNA are 
shown bound specifically to the DNA (magenta; second panel). All Qdot-nucleosomes 
were retracted as well as DNA when buffer flow stopped, indicating that the Qdots are on 






Figure 2.6: Verification of human nucleosomes reconstituted on 13x601 λ-DNA. (A) 
Schematic of 13x601 λ-DNA substrates. (B) Image of DNA curtain of human nucleosomes 
that were specifically formed at 13x601 region on λ-DNA. The 13x601 sequence (2,330 
bp) was incorporated via Xho1 and NheI restriction sites on λ-DNA. All nucleosomes were 
retracted when the buffer flow was turned off (bottom panel), indicating that all Qdot-
nucleosomes deposited on 13x601 are on DNA. (C) Positioning distribution histogram of 
human nucleosomes deposited on 13x601 λ-DNA. The binding density of nucleosomes on 
DNA (blue) was fit to a Gaussian distribution (red) that shows the center of 34.3 (kb) ± 





Figure 2.7: Counting of reconstituted human nucleosomes on wild-type λ-DNA. (A) 
Representative images of various numbers of nucleosomes per DNA. (B) Histogram of 
frequency of nucleosome binding per DNA (blue) was fit to a Poisson distribution with the 
mean of the data (red). (C) The number of nucleosomes as a function of DNA:octamer 
ratio. The standard deviation of each data set is shown as a black line. (D) The intensity of 
Qdots per DNA as a function of number of nucleosomes per DNA. The measured 









Figure 2.8: Human nucleosome distribution on λ-DNA. (A) Probability of A-T or G-C 
content on λ-DNA is shown in top panel. Distribution histogram of positions of human 
nucleosomes (middle panel, blue) displays	that nucleosomes have less preference for A-T 
rich regions. Yeast data of the positioning distribution histogram(162) was overlaid with 
the human data deposited on λ-DNA (bottom). (B) The normalized frequency data of 
human and yeast were assessed using Pearson correlation analysis. Blue is scattered data 








Chapter 3.  Intrinsically Disordered Regions Promote Resetting Steps in 
Eukaryotic Mismatch Repair 
 
Credit section for this chapter 3: Yoori Kim, Christopher Furman, and Carol Manhart 
collaborated for this work. C.F. purified proteins, performed DNA binding, ATPase, and 
genetic assays. C.M. performed gel-based nuclease assays. Y.K. performed and analyzed 




Intrinsically disordered regions (IDRs) are structurally heterogeneous protein domains that 
encode diverse functions. IDRs are conformationally flexible, facilitating interactions with 
multiple partners through intramolecular and intermolecular mechanisms (2, 167). IDRs 
are often found as linkers connecting functional domains where they can regulate protein 
stability (167). IDRs are prevalent in chromatin-binding proteins, and the IDRs in these 
proteins have been implicated in bridging DNA strands, chromatin remodeling, and 
interacting with other key proteins in DNA metabolic pathways (28, 29). Moreover, IDRs 
in transcription factors and single-strand DNA binding (SSB) proteins have been reported 
to tune the DNA binding affinities of these proteins (34, 110, 168–171). Whether these 
IDRs also regulate scanning on chromatin and other catalytic processes is an open question. 
This is partly because mutations in such regions often do not confer a specific phenotype, 
and in some cases, the amino acid sequences contained within IDRs, which are typically 
poorly conserved among family members, can be critical for the function of a specific IDR-
containing protein. Using the mismatch repair protein Mlh1-Pms1 as a case study, we 
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explore the role of IDRs in regulating the DNA scanning and enzymatic activities of a 
critical eukaryotic DNA repair factor.  
 The MutL homolog (MLH)-family protein Mlh1-Pms1 is essential for eukaryotic 
DNA mismatch repair (MMR). Mlh1-Pms1 organizes into a ring-like structure that links 
the ordered N- and C-terminal domains via 160-290 amino acid-long IDRs (108, 109, 172–
175) (Figure 3.1A). Mlh1-Pms1 searches for MutS homologs (MSH) bound to DNA 
mismatches (108, 163, 176). A latent MLH endonuclease activity then nicks the newly-
synthesized DNA strand resulting in excision of the mismatch(177). This activity requires 
PCNA, and multiple nicks are thought to be necessary for the excision step of MMR (79, 
80, 85, 103, 178–181).  
 All MLH-family proteins encode an IDR between the structured N- and C-termini. 
However, the functional role(s) of the IDRs in Mlh1-Pms1 is enigmatic. The composition 
and length of the MLH IDRs are critical for efficient MMR in yeast, and missense/deletion 
mutations within these linkers are found in human cancers(60, 109, 182). We previously 
proposed that the Mlh1-Pms1 IDRs are sufficiently long to accommodate a nucleosome 
within the complex, possibly allowing Mlh1-Pms1 to navigate on chromatin in vivo(81, 
163). In support of this model, Mlh1-Pms1 foci show a dynamic behavior consistent with 
a rapid identification of lesions(78). In addition, the Mlh1-Pms1 IDRs display nucleotide-
dependent conformational transitions, with ATP binding bringing the N- and C-terminal 
subunits close together(94, 97, 183). This ATPase activity is required for MMR in vivo and 
can stimulate the endonuclease activity in vitro (77, 92, 105, 178, 184). ATP-dependent 
conformational rearrangements involving the IDRs are hypothesized to position bound 
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DNA near the endonuclease active site and presumably change Mlh1-Pms1 affinity for 
DNA(94, 97, 105). Together, these studies suggest that MLH proteins may use 
conformational changes mediated by the ATP cycle to modulate affinity for DNA, navigate 
on chromatin, and introduce nicks on a DNA substrate for efficient MMR. However, these 
possible functions of the IDRs have not been tested directly. 
 Here, we use a combination of genetics, ensemble biochemistry, and single-
molecule biophysics to investigate how the Mlh1-Pms1 IDRs promote both DNA scanning 
and nuclease activities. We show that both the sequence composition and the precise length 
of the IDRs are required for optimal MMR in vivo. Having mapped genetic requirements 
for MMR, we next biochemically characterized a double linker deletion (DLD) mutant that 
was almost completely defective in MMR (DLDnull), and another linker deletion mutant 
that retains partial in vivo MMR function (DLDMMR). Interestingly, both mutants can bind 
and diffuse on DNA, retain single-round endonuclease activities, but show reduced DNA-
dependent ATPase and nucleosome bypass activities. Furthermore, DLDnull is unable to 
navigate dense nucleosome arrays and is defective in multiple rounds of DNA nicking. 
These results establish that the IDRs license Mlh1-Pms1 to navigate chromatin and nick 
DNA at multiple sites to promote efficient MMR in vivo. They suggest that the IDRs play 
a critical role in regulating how a DNA repair enzyme scans chromatin for a specific target 
and how the enzyme activates its endonuclease activity. More broadly, these results expand 
the functions of IDRs in regulating the DNA scanning and enzymatic activities of 




Materials and Methods 
 
Bulk biochemical assays 
DNA substrates for bulk biochemical assays:  pUC18 (Invitrogen) was used as the closed 
circular substrate for endonuclease assays presented in Figure 3.6A. A 49-mer 
homoduplex DNA substrate was labeled on the 5’ end with 32P labeled phosphate using 
T4 polynucleotide kinase (New England Biolabs). Unincorporated nucleotide was 
removed using a P30 spin column (BioRad). The two oligonucleotides were annealed by 
combining end-labeled AO3142 with a 2-fold molar excess of unlabeled AO3144-5’-
CACGCTACCGAATTCTGACTTGCTAGGACATCTTTGCCCACGTTGACCC-3’ in 
buffer containing 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM MgCl2, and 0.1 mM 
EDTA.  Annealing was accomplished by incubating the DNA substrates at 95 °C for 5 
min, followed by cooling to 25 °C at a rate of 1 °C/min. Following annealing, excess 
single-stranded DNA was removed using an S300 spin column (GE). 2.7 kb pUC18 for 
endonuclease assays on circular DNA was purchased from Thermo. For Figure 3.6B, 4.4 
kb pBR322 plasmid (Thermo) was linearized using HindIII (NEB) by incubation at 37 ºC 
for 60 min, followed by enzyme inactivation at 80 ºC for 20 min. Linearized fragments 
were isolated using a PCR clean-up kit (Zymo Research). 
 
Protein purification:  Yeast WT, DLDMMR and DLDnull Mlh1-Pms1 variants were purified 
from galactose-induced S. cerevisiae BJ2168 (MATa, ura3–52, leu2–3, 112, trp1–289, 
prb1–1122, prc1–407, pep4–3) containing expression vectors as previously described(109, 
185). Mlh1 contains a FLAG tag at position 499 in wild-type at the equivalent position in 
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Mlh1 truncation mutants. Yeast RFC and PCNA were expressed and purified from E. coli 
as described previously(186, 187). RPA-RFP was expressed and purified from 
Rosetta(DE3)/pLysS cells as described previously (188).  
  
Endonuclease assay:  Endonuclease reactions were performed in a buffer containing: 20 
mM HEPES- KOH (pH 7.5), 20 mM KCl, 2.5 mM MnSO4, 0.2 mg/mL BSA, and 1 % 
glycerol(189). Reactions were stopped by the addition of 0.1 % SDS, 14 mM EDTA, and 
0.1 mg/mL Proteinase K (NEB). For reactions on a circular DNA substrate, products were 
resolved by 1.2 % agarose gel containing 0.1 µg mL-1 ethidium bromide, which causes 
covalently closed circular DNA isoforms to separate from nicked DNA product. Gels were 
run in 1x TAE (Tris-acetate-EDTA) at 100 V for 45 min. Negative control lanes were used 
as background and were subtracted out of reported quantifications. Endonuclease assays 
on linear substrates were carried out and stopped as described for circular DNA substrates. 
Denaturing agarose gels consist of 1 % (w/v) agarose, 30 mM NaCl, 2 mM EDTA pH 7.5 
run in a buffer containing 30 mM NaOH and 2 mM EDTA(190). Immediately prior to 
sample loading, reactions were supplemented with 30 mM NaOH, 1 mM EDTA, 3 % 
glycerol, and 0.02 % bromophenol blue (final concentrations), heated for 5 min at 70 ºC, 
then cooled for 3 min on ice. Gels were run at 50 V for ~3 h. After running, alkaline agarose 
gels were neutralized in 0.5 M Tris base (pH 7.5) for 30 min and stained with 0.5 µg mL-1 





 Filter binding assay:  DNA binding assays were performed as described previously (191). 
Briefly, 20 µL reactions containing 4 nM 32P-labeled homoduplex substrate and 11 nM 
unlabeled homoduplex substrate were combined with increasing amounts of protein in a 
reaction buffer containing 20 mM Tris-HCl (pH 7.5), 0.01 mM EDTA, 2 mM MgCl2, 40 
µg mL-1 BSA, and 0.1 mM DTT. Assays with nucleotide contain 1 mM ATP. Reactions 
were incubated for 10 min at 30 ºC after addition of WT, DLDMMR and DLDnull Mlh1-Pms1. 
Reactions were then filtered through KOH-treated nitrocellulose filters using a Hoefer 
FH225V filtration device for approximately 1 min. Filters were analyzed by scintillation 
counting to determine DNA binding efficiency. 
 
ATPase assay:  ATPase activity was determined using the Norit A absorption method as 
described previously(189). Briefly, 30 µL reactions contained 0.4 µM of Mlh1-Pms1 (WT, 
DLDMMR and DLDnull), 100 µM [γ-32P]-ATP, 20 mM Tris, pH 7.5, 2.0 mM MgCl2, 0.1 
mM DTT, 1 mM MnSO4, 75 mM NaCl, 1 % glycerol, 40 µg/ml BSA. Reactions were 
incubated for 40 min at 37 °C. When specified, DNA (49-mer homoduplex DNA substrate 
as described above) and PCNA were included at 0.75 µM and 0.5 µM, respectively. 
  
Strains and plasmids: Yeast strains were grown in yeast extract/ peptone/dextrose, minimal 
complete, or minimal selective media (192). Full details of plasmid and strain constructions 
are available upon request. Expression vectors were derived from pMH1 (GAL1-MLH1-
VMA-CBD,2µ, TRP1) and pMH8 (GAL10-PMS1,2µ, LEU2)(185). 
  
Linker arm replacement series:  A series of ARS-CEN vectors were created to test if the 50 
amino acid deletion made in the Pms1 linker arm (pms1Δ584–634) could be replaced by 
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other sequences. These vectors were derived from pEAA238, which expresses PMS1 from 
its native promoter (193). Vectors used to overexpress and purify Mlh1-Pms1 were derived 
from pMH1 (GAL1-MLH1-VMA-CBD,2µ, TRP1) and pMH8 (GAL10-PMS1,2µ, 
LEU2)(185). Insertion plasmids were constructed using NEB HiFi DNA Assembly cloning 
(pEAA644-656) and Q5 mutagenesis (pEAA659-665). The desired DNA sequence (PCR 
amplified from specific plasmid or constructed as gBlocks, IDT) was inserted into the 
deleted region (amino acids 584 to 634) of the Pms1 linker. The DNA sequence of vectors 
constructed using PCR amplified vector backbones and linker inserts were confirmed by 
DNA sequencing (Cornell BioResource Center). 
 
lys2::insE-A14 reversion assay:  Assays were performed by Chris Furman as described 
previously(109). Briefly, pEAA238 (PMS1), pEAA548 (pms1∆584-634) and derivative 
linker insertion plasmids of pEAA548 were transformed into EAY3097 (MATa, ura3–52, 
leu2Δ1, trp1Δ63, his3Δ200, lys2::insE-A14, pms1Δ::KanMX4) using standard 
methods(192, 194). Plasmids were maintained by growing strains in minimal selective 
histidine dropout media. When tested in combination, pEAA238, pEAA548 (pms1∆584-
634) or derivative linker insertion plasmids were co-transformed with pEAA213 (MLH1) 
or pEAA526 (mlh1∆348–373 (FLAG499)) into EAY1365 (MATa, ura3–52, leu2Δ1, 
trp1Δ63, his3Δ200, lys2::insE-A14, mlh1Δ::KanMX4, pms1Δ::KanMX4). Plasmids were 
maintained by growing strains in minimal selective histidine and leucine dropout media. 
Null controls were transformed with pRS413 and pRS415 dummy vectors (195). Rates of 
lys2::insE-A14 reversion were calculated as µ=f/ln(N·µ), where f is reversion frequency and 
N is the total number of revertants in the culture(196). For each strain, 15–45 independent 
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cultures, obtained from two to three independent transformants bearing a unique allele, 
were assayed to determine the mutation rate; 95% confidence intervals and all computer‐
aided rate calculations were performed as previously described(109). 
 
Single-molecule experiments and analysis 
Imaging Mlh1-Pms1 on DNA curtains: The Mlh1-Pms1 complexes used in this study 
contain a FLAG epitope tag at residue 499 on the Mlh1 subunit. 25 nM of FLAG-tagged 
proteins were conjugated with 30 nM biotinylated anti-FLAG antibody (Sigma-Aldrich, 
F9291-2MG) and 25 nM streptavidin QDs (Life Tech, Q10163MP) in a total volume of 60 
µL on ice for 7 minutes. The mixture was supplemented with 100 µL biotin and diluted to 
a total volume of 150 µL in BSA buffer (40 mM Tris-HCl pH 8.0, 1 mM MgCl2, 0.2 mg 
mL-1 BSA, 50 mM NaCl, 1 mM DTT). The fluorescently labeled proteins were injected 
into the flowcell immediately after the conjugation at a 200 µL min-1 flow rate. 
The DNA binding affinity of Mlh1-Pms1 is sensitive to salt concentration. We, 
therefore, used a two-step procedure to efficiently load the fluorescently-labeled protein 
onto DNA curtains. Mlh1-Pms1 was initially injected into the flowcell containing double-
tethered DNA curtains with BSA buffer that includes low salt to assist its DNA binding.  
Next, the buffer was switched to imaging buffer (40 mM Tris-HCl pH 8.0, 1 mM MgCl2, 
0.2 mg mL-1 BSA, 150 mM NaCl, 1 mM DTT, 1 mM nucleotides as indicated). After the 
flowcell was completely washed with the imaging buffer, flow was terminated to observe 




Fluorescent labeling of nucleosomes: Nucleosomes were fluorescently labeled in situ after 
Mlh1-Pms1 diffusion trajectories were recorded on the DNA substrates. An anti-HA 
antibody targeting (Immunology Consultants Laboratory, RHGT-45A-Z) was diluted 100-
fold in BSA buffer and injected into the flowcell at 10 nM final concentration for 5 minutes. 
Next, 10 nM secondary antibody was injected and incubated for 7 minutes, then buffer 
flow was stopped to visualize nucleosomes on double-tethered DNA molecules. We have 
used anti-rabbit Alexa488 (Life Tech, A-11008) or anti-rabbit ATTO647N (Sigma-Aldrich, 
40839-1mL) for the secondary antibody.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 
Particle tracking: Fluorescently-labeled proteins were tracked in ImageJ with a custom-
written particle tracking script (available upon request) and the resulting trajectories further 
analyzed in MATLAB (R2015a, Mathworks). The positions of labeled proteins were 
determined by fitting every single fluorescent particle to a two-dimensional Gaussian 
distribution, and the series of time-dependent sub-pixel positions generated each trajectory.  
 Mlh1-Pms1 diffusion coefficients were determined by using the trajectories of individual 
moving molecules on double-tethered DNA curtains in the absence of buffer flow. The 
one-dimensional (1D) mean squared displacement (MSD) of each particle was determined 








where N is the total number of frames in the trajectory, n is the number of frames for a 
given time interval and ranges from 1 to N, Δt is the frame rate, and yi is the Mlh1-Pms1 
position at frame i. The MSD was calculated using the first ten time intervals (e.g. Δt = 
	
58	
0.05 s to 0.5 s when the frame rate was 0.05 s) and plotted as a function of Δt. Plots were 
fit to a line and the slope was used to calculate diffusion coefficients of individual Mlh1-
Pms1 molecules. Diffusion coefficients were calculated for ≥ 30 molecules in all 
experiments and are reported as a mean ± standard error of the mean (S.E.M). 
  
Measuring single nucleosome bypass frequencies: Fluorescently-labeled Mlh1-Pms1 was 
loaded onto double-tethered nucleosomal DNA curtains as described above. All 
nucleosome bypass experiments were done in imaging buffer containing 150 mM NaCl 
and either no nucleotide or with 1 mM ATP. We determined each collision and bypass 
event from individual Mlh1-Pms1 trajectories. First, a ‘collision zone’ was defined around 
each nucleosome position. Next, the positions of diffusing Mlh1-Pms1 were plotted 
relative to the center of the nucleosome collision zone. The number of collisions was 
determined by counting the number of times that Mlh1-Pms1 entered the nucleosome 
collision zone. Bypass events were defined as collisions that had Mlh1-Pms1 cross from 
the first to the second side of the nucleosome collision zone. Non-bypass events had Mlh1-
Pms1 start and end the collision on the same side relative to the nucleosome. To compare 
the probability of bypassing single roadblock between different conditions with a statistical 
test, we coded each bypass event as ‘1’ and no bypass as ‘0’, and fit the data to a binary 
distribution using MATLAB.  
  
Statistical methods: We conducted the two-sample Kolmogorov-Smirnov (K-S) test to 
determine whether average diffusion coefficient differ based on nucleotide types using the 
PAST3 software package (197). Error bars on the quantified single nucleosome bypass and 
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percentage of moving molecules were calculated in MATLAB using bootstrap analysis 
with replacement (198). P-values between conditions on single nucleosome bypass 
experiments were determined in MATLAB using a binary regression model. The 
significance threshold was set at 0.05 in all tests. 
 
Single-molecule nicking assay: 5 nM PCNA was loaded by 1.5 nM RFC on double-tethered 
DNA curtain in Mlh1-Pms1 endonuclease buffer (40 mM Tris-HCl pH 8.0, 0.2 mg mL-1 
BSA, 50 mM NaCl, 2 mM MnCl2, 1 mM DTT, 1 mM ATP) (199). MgCl2 was used instead 
of MnCl2 for manganese negative control. RFC was washed out by injecting endonuclease 
buffer with 300 mM NaCl for 2 minutes. 20 nM Mlh1-Pms1 complexes were loaded on 
the PCNA-containing DNA and incubated for 20 min at 30˚ C followed by washing with 
1 M NaCl for 2 min. 50 nM RPA-RFP was then injected to label any gaps larger than 10 
nucleotides. For a photobleaching experiment, RPA-RFP was imaged by a 532 nm laser 
(100 mW at the prism face) with 250 ms exposure time. To assess RPA foci, data were 




The IDRs of Mlh1-Pms1 are critical for mismatch repair.  
We first examined whether the IDRs of Mlh1 (~160 amino acids) and Pms1 (~290 
amino acids) contain functionally important amino acids (Figure 3.1A). Our previous study 
established that MMR was ablated in yeast cells that lacked the Mlh1 IDR residues 348-
373 and Pms1 residues 548-634 (MMR-null double-linker deletion, DLDnull; mlh1Δ348-
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373-pms1Δ584-634). This result was surprising because deleting the same residues in the 
individual subunits conferred very mild MMR defects (109). Here, we expand on this early 
study by defining whether the composition and/or the lengths of the IDRs are critical for 
supporting MMR.   
We first tested whether restoring the IDR of pms1Δ584-634 to its full-length 
rescued MMR. PMS1 was chosen because truncating its IDR at different positions showed 
only minor MMR defects and thus may be more likely to restore function with a synthetic 
linker (109). The substitutions included random scrambling of the 50 critical amino acids 
(584-634) in Pms1, as well as two biophysically characterized serine-rich regions that were 
equal or longer than 50 amino acids (obtained from the Herpes Virus ICP4 and Neurospora 
crassa Su9 proteins) (200, 201). All substitutions were initially examined in the wild-type 
(WT) MLH1 background, where they did not restore function. The MMR defects conferred 
by these pms1 mutants were similar to the pms1Δ584-634 allele, indicating that the 
insertions are unlikely to disrupt the stability of the Mlh1-Pms1 complex (Figure 3.1B and 
Figure 3.2). In the mlh1Δ348-373 background, PMS1 linker substitutions all conferred a 
nearly-null MMR phenotype that was reminiscent of the DLDnull MMR defect. We also 
performed a full-length linker swap between the IDRs in MLH1 and PMS1 (Figure 3.1B 
and Figure 3.2); these alleles, as swaps or single substitutions, were unable to confer MMR 
function. Lastly, fine-scale mapping of the PMS1 584-634 region using scrambled and 
single amino acid substitution analyses identified a 20 amino acid region, 594-613, that 
plays a critical role for the function of the linker, and a single substitution, pms1-Y613A, 
conferred a mutator phenotype, (p-value <.00001 to WT; p-value<.00001 to  pms1Δ584-
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634 compared by Mann-Whitney U test) (Figure 3.2). Together these experiments establish 
that the specific sequence of the IDR, but not the flexibility, length or disorder is important 
for efficient MMR.   
 
IDRs regulate Mlh1-Pms1 ATPase activity in the presence of DNA and PCNA.  
 Mlh1-Pms1 is a DNA-stimulated ATPase and PCNA-activated endonuclease. 
Nucleolytic cleavage of the newly-synthesized DNA strand by Mlh1-Pms1 is proposed to 
be a critical strand discrimination signal during MMR (178, 202, 203). We sought to 
understand the role(s) of the IDRs in promoting the enzymatic activities of Mlh1-Pms1. 
We compared WT Mlh1-Pms1 to two additional mutant complexes: one mostly functional 
in MMR (DLDMMR; mlh1Δ348-373-pms1Δ437-487), and a second defective (DLDnull; 
mlh1Δ348-373-pms1Δ584-634) (Figure 3.3). 
 All Mlh1-Pms1 variants bound similarly to a 49 bp oligonucleotide in the absence 
of ATP (Figure 3.3B). In the presence of ATP, Mlh1-Pms1 displayed reduced binding to 
DNA, but both DLDMMR and DLDnull displayed DNA binding levels that were higher than 
WT. These results show that the two DLD complexes are impaired in ATP-dependent 
interactions with DNA. The ATPase activities of the WT complex are stimulated by DNA 
and PCNA (94, 180). However, neither DLD complex exhibited such stimulation (Figure 
3.3C). We conclude that the IDRs facilitate interactions between Mlh1-Pms1 and DNA, 
and also promote ATP hydrolysis. Remarkably, both DLDMMR and DLDnull showed similar 
defects in DNA binding and ATPase activities but had very different MMR phenotypes 




The IDR linker promotes facilitated 1D diffusion of Mlh1-Pms1 on DNA.  
 DNA-binding proteins, including Mlh1-Pms1, locate their targets using facilitated 
1-dimensional (1D) diffusion along the genome (81, 163, 176, 204). Based on the 
biochemical results presented above, we hypothesized that the IDRs of Mlh1-Pms1 are 
essential for efficient 1D diffusion on chromatin. I examined Mlh1-Pms1 diffusion on 
double-tethered DNA curtains (Figure 3.4). In this assay, a 48.5 kb-long DNA substrate is 
extended over a fluid lipid bilayer between two microfabricated chromium barriers (50, 
205, 206). The lipid bilayer provides a biomimetic surface that passivates the flowcell 
surface from non-specific adsorption by DNA-binding proteins. A single FLAG epitope 
was inserted at amino acid 499 of Mlh1 for downstream fluorescent labeling. The FLAG 
epitope does not impact Mlh1-Pms1 activities in vitro and in vivo (81, 163). For fluorescent 
labeling, Mlh1 was conjugated with an anti-FLAG antibody harboring a fluorescent 
quantum dot (QD) (81, 163). Using this assay, I characterized WT Mlh1-Pms1, as well as 
DLDMMR and DLDnull variants. All three Mlh1-Pms1 complexes readily bound DNA and 
>90% of the molecules rapidly diffused along the entire length of the DNA substrate 
(Figure 3.4C; WT: 97%, N=62/64; DLDMMR: 97%, N=79/81; DLDnull: 90%, N=60/67). 
Analysis of the movement showed linear mean-squared displacement (MSD) plots, 
verifying that all three Mlh1-Pms1 complexes freely diffuse on DNA. 
ATP binding to Mlh1-Pms1 results in dimerization of the N-terminal domains, 
compaction of the IDRs, and the formation of a ring-like sliding clamp on DNA (87, 92, 
94, 97). To probe the functional significance of this conformational change, I measured the 
diffusion coefficients of the Mlh1-Pms1 variants as a function of ATP. Diffusion 
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coefficients in the ATP-bound state were significantly increased compared to the apo (no 
nucleotide) condition for all complexes. These results are consistent with a prior single-
molecule report of ATP-dependent diffusion of E. coli MutL homodimer (204). However, 
compared to WT and DLDMMR, the mean DLDnull diffusion coefficient is ~six-fold lower 
on DNA in the presence and absence of ATP (Figure 3.4D and Table 3.1). While DLDnull 
displayed the lowest diffusion coefficient of all the complexes in the absence or presence 
of ATP, DLDnull and DLDMMR displayed similar diffusion coefficients in the presence of 
ADP or AMP-PNP. We conclude that the IDRs of Mlh1-Pms1 are critical for efficient 
facilitated diffusion on DNA.  
 
IDRs promote facilitated diffusion on nucleosome-coated DNA. 
 Mlh1-Pms1 must efficiently traverse chromatin to locate mismatch-bound MSH 
complexes. To investigate how the IDRs regulate movement on chromatin, I imaged Mlh1-
Pms1 on nucleosome-coated DNA substrates. Nucleosomes were assembled using salt 
gradient dialysis with increasing concentrations of histone octamers to DNA molecules to 
recapitulate both sparse and dense nucleosome arrays (132, 163). Single nucleosomes were 
visualized via a fluorescent antibody directed against a triple HA epitope on the N-terminus 
of H2A. Nucleosomes were distributed over the entire length of the DNA molecule, with 
a weak preference for GC-rich segments, as described previously (Figure 2.8) (162). 
I first determined whether the Mlh1-Pms1 IDRs regulate diffusion past a single 
nucleosome. DNA substrates with one to seven nucleosomes were assembled into double-
tethered DNA curtains. Mlh1-Pms1 was added to the flowcell prior to fluorescently 
labeling the nucleosomes. Keeping the nucleosomes unlabeled guaranteed that Mlh1-Pms1 
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was not blocked by the H2A-targeting antibody. After recording 10-15 minutes of Mlh1-
Pms1 diffusion, a fluorescently labeled anti-HA antibody visualized the nucleosome 
positions. Diffusing Mlh1-Pms1 complexes encountered and occasionally bypassed 
individual nucleosomes (Figure 3.6). To quantitatively determine the probability of 
bypassing a single nucleosome, I defined a ‘collision zone’ for each nucleosome which 
encompasses three standard deviations of the spatial resolution of our single-molecule 
assay (0.08 µm; ~ 300 bp) (Figure 3.5). Diffusing Mlh1-Pms1 that entered this collision 
zone from one side of the nucleosome and emerged from the other side was counted as a 
bypass event. Events where Mlh1-Pms1 entered and emerged from the same side of the 
nucleosome collision zone were scored as non-bypass encounters. This quantification 
likely underestimates the frequency of microscopic Mlh1-Pms1 nucleosome bypass events 
that are below our spatial resolution but does not change any of the underlying conclusions 
comparing the different complexes.  
WT Mlh1-Pms1 bypassed nucleosomes 30 ± 0.3% of the time (Table 3.2). A 
molecule that travels via a 1D random walk involving facilitated diffusion has a 50% 
probability of stepping forward or backward on DNA. This 50% probability value is the 
maximum theoretical bypass probability in the absence of any nucleosome obstacles. Thus, 
Mlh1-Pms1 is capable of efficiently bypassing a nucleosome obstacle. In contrast, both 
DLDMMR and DLDnull complexes had a 2-fold reduced nucleosome bypass frequency (18 
± 0.5%; N=29 for DLDMMR; 19 ± 0.2%; N=27 for DLDnull).  
Next, I explored how ATP-induced conformational changes affect nucleosome 
bypass by Mlh1-Pms1 (Figure 3.6C). In the presence of ATP, all Mlh1-Pms1 variants 
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exhibited a reduced bypass probability, with a significantly larger, ~2 to 3-fold, decrease 
in nucleosome bypass probability for both DLD variants. The decrease in bypass 
probabilities for DLDMMR and DLDnull mirrors their ATPase activities (Figure 3.3C). Taken 
together, these data suggest that ATP-dependent dimerization of the N-terminal domains 
accompanied by conformational compaction of the IDRs reduces dynamic movement on 
nucleosome-coated DNA.  
We reasoned that the combination of a reduced diffusion coefficient and less 
efficient nucleosome bypass observed with DLDnull may compromise its ability to navigate 
on dense nucleosome arrays. To test this, I increased the histone octamer to DNA ratio 
during salt dialysis to deposit >10 nucleosomes per DNA substrate (Figure 3.7B). At this 
high density, each nucleosome is optically indistinguishable due to the diffraction limit of 
light. Nonetheless, by using two-color fluorescent imaging we can still track individual 
diffusing Mlh1-Pms1 complexes on this nucleosome-coated DNA substrate (Figure 3.7). 
The 1D diffusion of all Mlh1-Pms1 complexes was restricted on this high nucleosome 
density substrate compared to naked DNA. Notably, while 1D diffusion coefficients of WT 
and DLDMMR decreased by 3-fold compared to naked DNA, the DLDnull diffusion 
coefficient decreased 12-fold on this chromatinized DNA substrate (Figure 3.7E). Thus, 
the IDRs are important for promoting rapid facilitated diffusion on naked DNA but are 
especially critical for navigating on chromatin. 
 
The IDRs are required for multiple rounds of endonucleolytic cleavage.  
 After MSH recognition, Mlh1-Pms1 deposits multiple nicks on the mismatch-
containing DNA strand for efficient MMR (80, 207). Motivated by the importance of the 
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IDRs in promoting diffusion on both naked and nucleosome-coated DNA, we tested how 
these domains regulate Mlh1-Pms1 endonuclease activity. We first assayed the ability of 
Mlh1-Pms1 variants to nick supercoiled DNA in a well-established mismatch-independent 
endonuclease reaction (105, 178, 180, 202). This assay requires the ATP-dependent clamp 
loader RFC to load PCNA on the closed circle DNA substrate (208, 209). The 
endonuclease activity of WT Mlh1-Pms1 was indistinguishable from the DLDnull and 
DLDMMR variants (Figure 3.8A). However, this assay cannot distinguish between singly- 
and multiply-nicked DNA substrates. This assay also cannot report the ATP dependence 
of the Mlh1-Pms1 endonuclease activity because ATP is required for RFC-dependent 
PCNA loading. To resolve these limitations, we established the alkaline gel-based and 
single-molecule endonucleolytic assays described below. 
We directly tested the role(s) of ATP in Mlh1-Pms1 endonuclease activation on 
linear DNA substrates analyzed by denaturing gel electrophoresis. PCNA can thread onto 
the ends of linear DNA, abrogating the need for RFC and ATP (Figure 3.8B) (180, 202, 
210). We observed that Mlh1-Pms1 endonuclease requires PCNA and is further enhanced 
by ATP binding. ATP hydrolysis was not required because ATPγS could support the 
reaction to the same extent or better than ATP, as suggested for the E. coli and Bacillus 
MutL (87, 94, 105). Although the DLDMMR variant hydrolyzed linear DNA to 
approximately the same extent as wild-type Mlh1-Pms1, DNA degradation was attenuated 
with the DLDnull variant (Figure 3.8B). This was seen in the presence of ATP, but less so 
in the presence of ATPγS. In the assay in Figure 3.8B, extensive nicking on each DNA 
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molecule accounted for the observed substrate loss, and the reduced nicking by the DLDnull 
complex suggested another in vivo MMR defect.  
 Next, I developed a single-molecule assay to probe the limited nicking that likely 
occurs for DLDnull in vivo. This reaction was carried out in two steps. First, PCNA was 
loaded by RFC on double-tethered DNA curtains in the presence of ATP, as described 
previously (199). After flushing out RFC, Mlh1-Pms1 was incubated in the flowcell for 20 
minutes (Figure 3.9A). PCNA and Mlh1-Pms1 were washed out by 1 M NaCl followed by 
injecting 50 nM RPA-RFP to visualize the ssDNA gaps made by multiple rounds of Mlh1-
Pms1 endonuclease activity (Figure 3.9A-C). These ssDNA gaps arise from loss of short 
oligos formed by multiple nicks that are deposited in close proximity by Mlh1-Pms1. 
Alternatively, closely-spaced nicks may allow fraying of ssDNAs that are subsequently 
bound and displaced by RPA(211). Note that we would not be able to detect RPA foci if 
the nicks on the same strand created by Mlh1-Pms1 were far apart. I quantified the number 
of RPA foci per DNA and the number of RPA per focus via single-molecule 
photobleaching. RPA preferentially binds ~30 nt of ssDNA, but individual RPA molecules 
can bind ssDNA as short as 10 nucleotides (212, 213). Thus, I estimate that puncta with 
one RPA contain approximately 10-30 nt of ssDNA, whereas puncta with three or more 
RPA expose > 60 nt of ssDNA. Interestingly, DLDnull generated 6-fold fewer RPA foci 
(0.07 ± 0.02 RPA/DNA; N=307) than WT Mlh1-Pms1 (0.40 ± 0.02 RPA/DNA; N=382). 
In contrast, DLDMMR was only mildly compromised (0.28 ± 0.02 RPA foci/DNA; N=420) 
compared to WT complex (Figure 3.9D). I also estimated the length of the exposed ssDNA 
by counting the number of RPA molecules bound on DNA. The number of RPA per focus 
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was comparable for DLDnull (1.1 ± 0.56 RPA; N=20) and DLDMMR (0.9 ± 0.58 RPA; N=68) 
but was substantially lower than WT Mlh1-Pms1 (2.6 ± 1.2 RPA; N=79) (Figure 3.9E). 





All MLH proteins—from the E. coli MutL to the human Mlh1-Pms1—contain IDRs that 
link the structured N- and C-terminal domains (Figure 3.1). The importance of IDRs have 
been recognized in both bacterial and eukaryotic MMR, but the functions of this domain 
have remained elusive (108, 109). Here, we show that shortening, scrambling, lengthening, 
or swapping the IDRs caused mild to severe MMR defects, and even a single amino acid 
substitution in the IDR of Pms1, Y613A, caused an MMR defect in vivo (Figure 3.2). We 
therefore used three representative Mlh1-Pms1 complexes (WT, DLDMMR, DLDnull) to 
further probe the mechanistic implications of altered IDRs.  
 The Mlh1-Pms1 IDRs undergo conformational changes throughout the ATP 
hydrolysis cycle (87, 94, 97, 183). Upon ATP binding, Mlh1-Pms1 adopts a ring-like, 
scrunched conformation (97). (Figure 3.10). ATP hydrolysis reverts the complex back to 
the extended open state where it is likely to dissociate from DNA (87, 92, 94, 97). Here, 
we show that the ATPase activity is disrupted when the IDRs are shortened (Figure 3.3C), 
indicating that disrupting this conformational cycle feeds back on the ATPase activity 
encoded in the structured N-terminus of both subunits. These data motivated us to assay 
the roles of the IDRs in scanning DNA and nucleolytically processing the DNA.  
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 Mlh1-Pms1 locates MMR foci after MSH complexes recognize a DNA lesion in 
vivo (78). Therefore, Mlh1-Pms1 must scan the genome as nucleosomes are being 
assembled onto the newly synthesized DNA. Strikingly, the DLDnull complex is 
significantly impaired in 1D diffusion on naked DNA and this defect is further exacerbated 
on dense nucleosome arrays, where the diffusion coefficient of DLDnull is decreased by 12-
fold compared to that of WT Mlh1-Pms1 (Figure 3.7). The different activities of DLDnull 
and DLDMMR suggest that the residues spanning the 584-634 aa region in Pms1 are 
especially critical for MMR. These residues likely contribute to the conformational 
rearrangement of the entire complex. A second possibility is that the IDR reorganizes how 
DNA is channeled through the Mlh1-Pms1 complex. Further structural and biophysical 
studies will be required to probe the conformational transitions of these IDR variants on 
DNA. Taken together, our data establish that the IDRs regulate facilitated diffusion of 
Mlh1-Pms1 on both naked and nucleosome-coated DNA substrates.  
 Recent studies suggest that iterative nicking by multiple Mlh1-Pms1 complexes 
promote MMR by increasing the entry sites for EXO1 or stimulating EXO1-independent 
repair via strand displacement and/or exonucleolytic activities of Polymerase δ(79, 80, 85, 
179, 207). The IDRs may control this activity by regulating the facilitated diffusion of 
Mlh1-Pms1 on DNA and by ATP-dependent conformational rearrangements that bring the 
DNA strand close to the nuclease active site. Indeed, ATP-dependent structural 
rearrangement stimulates the nuclease activity in the bacterial MutL system(87, 105). 
Consistent with this idea, DLDnull was defective in carrying out multiple rounds of DNA 
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cleavage, as seen in both ensemble and single-molecule nuclease assays (Figure 3.8 and 
Figure 3.9).  
 Together with prior studies of nucleotide-dependent MLH conformations (79, 97, 
108, 183), we propose that the IDRs undergo structural rearrangements that change how 
the complex interacts with the DNA substrate (Figure 3.10). Mlh1-Pms1 rapidly diffuses 
on nucleosome-coated DNA in search of lesion-bound MSH complexes. When bound to 
ATP, the Mlh1-Pms1 acts as a stable sliding clamp on DNA and its endonuclease is 
activated by PCNA to nick DNA. Upon ADP and Pi release Mlh1-Pms1 enters the apo 
state and cycles off of DNA. The ATP binding/hydrolysis cycle is repeated, with a Mlh1-
Pms1 sliding clamp activated by PCNA to nick DNA at a different position. Consistent 
with this and variants of this model (79), DLDnull shows specific defects in 
dynamic processes requiring a functional ATP binding/hydrolysis cycle on long DNA 
substrates; e.g., diffusion on naked and nucleosome coated DNA (Figure 3.4D and Figure 
3.7E) and making multiple nicks (Figure 3.8 and Figure 3.9). DLDMMR and DLDnull 
complexes show similar defects in single step processes; e.g., DNA binding and ATPase 
activity on short oligonucleotides, single nicking (Figure 3.8A), and bypassing a single 
nucleosome (Figure 3.6). This model also explains why locking either DLDnull or DLDMMR 
in a single configuration by adding ADP or AMP-PNP results in similar diffusion kinetics. 
The combination of ATPase, facilitated diffusion, and endonuclease defects lead to the 
MMR catastrophe observed for the DLDnull mutant. A subset of these phenotypes explains 
the partial MMR defects of the other IDR variants that we assayed genetically (Figure 3.1B 
and Figure 3.2).  
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 Conformational rearrangements allow Mlh1-Pms1 to rapidly diffuse on DNA. 
Facilitated diffusion accelerates the search for MSH-bound lesions on chromatin. 
Importantly, the ATP hydrolysis cycle confers dynamic structural rearrangements that 
stimulate multiple nicks in the vicinity of the mismatch. More broadly, our results highlight 
that conformational changes in intrinsically disordered linkers can profoundly alter DNA 
interactions and enzymatic activities of neighboring structured domains. This work adds 
additional details to the emerging disorder-function paradigm emerging from biophysical 




Table 3.1. Nucleotide-dependent Mlh1-Pms1 diffusion coefficients 
Nucleotide 







(relative to WT) 
t-test K-S test 
None 
WT 0.507 ± 0.07 56 N/A 
DLDMMR 0.223 ± 0.04 41 0.1 0.01 
DLDnull 0.078 ± 0.01 39 1.5x10-6 6.7x10-9 
ADP 
WT 0.584 ± 0.07 46 N/A 
DLDMMR 0.303 ± 0.04 40 0.001 0.0007 
DLDnull 0.376 ± 0.14 34 0.15 0.001 
AMP-PNP 
WT 0.753 ± 0.18 30 N/A 
DLDMMR 0.451 ± 0.11 41 0.13 0.99 
DLDnull 0.275 ± 0.05 26 0.02 0.07 
ATP 
WT 0.918 ± 0.10 59 N/A 
DLDMMR 0.646 ± 0.10 50 0.069 0.007 
DLDnull 0.171 ± 0.02 42 8.2x10-8 9.3x10-13 
All data points were acquired in imaging buffer containing 150 mM NaCl.  
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WT 31 1361 0.30 ± 0.003 N/A  44 ± 44 
DLDMMR 29 1166 
0.18 ± 
0.005 2.8x10
-11  40 ± 29 
DLDnull 27 1033 
0.19 ± 
0.002 6.1x10
-9 0.54 38 ± 24 
ATP 
WT 34 1223 0.21 ± 0.007 N/A  35 ± 35 
DLDMMR 30 1572 
0.063 ± 
0.004 4.8x10
-28  56 ± 60 
DLDnull 30 1111 
0.070 ± 
0.002 1.9x10
-19 0.08 37 ± 30 








Figure 3.1: The IDR of Mlh1-Pms1 is critical for MMR in vivo. (A) Structural 
prediction of long IDRs in both Mlh1 (amino acids 335-499) and Pms1 (amino acids 364-
659) (214). Any value above 0.5 is considered disordered. (B) Schematic of IDR sequence 
changes made in Mlh1-Pms1, followed by the mutator phenotype conferred by the 
indicated alleles. +++ wild-type mutation rate, ++ hypomorph, – null.  See text for a 





Figure 3.2: In vivo MMR assay for various linker variants of Mlh1-Pms1. (A) 
Schematic of specific sequences that replace the IDRs in Pms1, followed by the mutator 
phenotype conferred by the indicated alleles in the MLH1 strain background. +++ indicates 
a wild-type mutation rate, ++, ++- and + indicate hypomorph phenotypes, and – indicates 






Figure 3.3: ATPase dependent DNA binding of Mlh1-Pms1. (A) Schematic of two 
double linker deletion mutants used in vitro study. (B) DNA binding activities for each 
complex analyzed by filter binding in the presence (dashed line) and absence (solid line) 
of 1 mM ATP. Mlh1-Pms1 variants were included at final concentrations of 12.5 nM, 25 
nM, 50 nM, 100 nM, and 150 nM in buffer containing 25 mM NaCl. DNA binding of a 49 
bp oligonucleotide was quantified by scintillation counting. Three replicates were averaged; 
error bars indicate ± one SD. (C) ATP hydrolysis activities of WT and mutant Mlh1-Pms1 
complexes (0.40 µM) were determined alone, and in the presence of PCNA (0.5 µM), or 
49-bp homoduplex DNA (0.75 µM), and both PCNA (0.5 µM) and 49-bp homoduplex 





Figure 3.4: The IDRs promote facilitated Mlh1-Pms1 diffusion on DNA. (A) 
Schematic of the DNA curtains assay. Fluorescently-labeled Mlh1-Pms1 is injected into 
the flowcell and visualized on double-tethered DNA substrates in the absence of buffer 
flow. (B) An image of Mlh1-Pms1 (magenta puncta) on double-tethered DNA molecules 
(green). To avoid interference from the DNA-intercalating dye, the DNA is not 
fluorescently stained during analysis of Mlh1-Pms1 movement on DNA. (C) A schematic 
(top) and representative kymographs of a WT, DLDMMR, DLDnull Mlh1-Pms1 diffusing on 
DNA. (D) Diffusion coefficients of Mlh1-Pms1 complexes in different nucleotide 
conditions. Boxplots indicate the median, 10th, and 90th percentiles of the distribution. P-
values are obtained from K-S test: * P-values <0.05, ** P-value < 0.01, and *** P-value 








Figure 3.5: Definition of ‘nucleosome zone' for bypass analysis. To determine the spatial 
resolution, a distribution of the net displacement of single nucleosomes was fit to a 
Gaussian distribution (red line). For analyzing single nucleosome bypass frequencies, the 







Figure 3.6: Analysis of nucleosome bypassing activity for three Mlh1-Pms1 complexes. 
(A) An illustration (top) and a representative kymograph of WT Mlh1-Pms1 diffusing past 
a nucleosome (bottom). (B) Trajectory analysis of single nucleosome bypass events. (C) 
The values obtained from the analysis shown in (B) are fit to binary logistic regression to 






Figure 3.7: The IDRs increase Mlh1-Pms1 movement on nucleosome-coated DNA. (A) 
A cartoon (top) of Mlh1-Pms1 movement on nucleosome-coated DNA. (B) A fluorescent 
image of double-tethered DNA curtain with > 10 nucleosomes (green) per DNA. The 
position of each nucleosome cannot be determined due to overlapping fluorescent 
nucleosome signals. Representative kymographs of DLDnull (magenta) on DNA containing 
4 ± 2 nucleosomes (top, green) or > 10 nucleosomes (bottom, green) in the absence of ATP 
(C) or with ATP (D). (E) Diffusion coefficients of the three Mlh1-Pms1 complexes on 
nucleosome-coated DNA. The solid and dashed green lines indicate the mean of the 
diffusion coefficients of WT and DLDnull on naked DNA, respectively. P-values are 
obtained from K-S test: * P-values <0.05, ** P value < 0.01, and *** P-value < 0.005. N.S. 





Figure 3.8: Bulk endonuclease assay for Mlh1-Pms1. (A) Endonuclease activity on 
closed circular DNA in the presence (+) or absence (-) of MnSO4, ATP, and yeast 
PCNA/RFC (left panel). Where + is indicated, the concentration of MnSO4 was 2.5 mM, 
ATP was 0.5 mM, RFC and PCNA were each 500 nM. The final concentration of WT 
Mlh1-Pms1 was 100 nM. In the presence of MnSO4, ATP, RFC, and PCNA at the above 
concentrations, Mlh1-Pms1 variants were titrated from 0-200 nM (right panel). Error-bars: 
SD of three replicates. (B) The amount of substrate lost was quantified on a single gel and 
expressed as a fraction by comparing to lane 2. The average fraction lost and SD were 
calculated from four replicates (left). Illustration (middle panel) and quantification (right 
panel) of the endonuclease activity of wild-type and mutant Mlh1-Pms1 complexes 
(titrated from 0-200 nM) on linear DNA. All reactions contain 500 nM PCNA, 0.5 mM 






Figure 3.9: Single-molecule endonuclease assay for Mlh1-Pms1. (A) Schematic of the 
single-molecule endonuclease assay. Formation of ssDNA gaps via PCNA-activated Mlh1-
Pms1 nuclease activity was visualized by injecting RPA-RFP into the flowcell. (B) 
Kymograph and (C) fluorescent intensity profile of an RPA-RFP punctum with a single-
step photobleaching event (arrow), indicating a single RPA-RFP molecule on the ssDNA. 
(D) The number of RPA foci per DNA molecule for the indicated Mlh1-Pms1 variants. (E) 
The number of RPA molecule per punctum for the three Mlh1-Pms1 complexes. To 
estimate the number of RPA molecules per ssDNA segment, the fluorescent intensity for 








Figure 3.10: A model of the conformational cycle of Mlh1-Pms1 in MMR. Mlh1-Pms1 
forms open or closed sliding clamps in the absence (apo) and presence of ATP, respectively 
(97). The IDRs in Mlh1-Pms1 are critical for transmitting ATP binding and hydrolysis 
states in the N-terminal domains to the C-terminal endonuclease domain. Mlh1-Pms1 loads 
onto DNA where it rapidly diffuses on DNA and efficiently bypasses nucleosome barriers 
in search of Msh complexes bound to mismatches. In the ATP bound form, the complex 
forms a sliding clamp, and its endonuclease is activated by PCNA to nick DNA. After 
catalyzing one or more nicks, the Mlh1-Pms1 then enters the apo conformation and cycles 
off of DNA. Another complex in the ATP bound sliding clamp mode is then activated by 




Chapter 4.  Efficient Modification of λ-DNA for Single-Molecule Study 
and PCNA Dynamics on Trinucleotide Repeat Structure 
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Single-molecule studies of protein-nucleic acid interactions frequently require site-specific 
modification of long DNA substrates. The bacteriophage λ is a convenient source of high 
quality long (48.5 kb) DNA. The long genomic λ-DNA is useful for observing proteins that 
package, transcribe, replicate, or diffuse on DNA (215). Moreover, the cosL and cosR 
ssDNA overhangs facilitate direct ligation of modified DNA handles. In addition, high-
quality recombinant DNA can be purified from lysogenic cells in large quantities. 
 Site-specific λ-DNA modification strategies generally fall within one of four 
categories: (i) restriction enzyme cleavage and ligation (216, 217); (ii) recombinase-
mediated modifications (218, 219); and (iii) insertion of extrahelical structures via 
oligonucleotide mimics, or (iv) nicking endonuclease (nickase)-based oligo replacement 
(220–224). To date, restriction enzyme cleavage and multi-step ligation in vitro is one of 
the most frequently used methods for modifying λ-DNA. However, this approach is 
technically challenging because multi-step intra-molecular ligation is inefficient. 
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Restriction enzyme-based cloning is also limited due to the few unique restriction sites 
within the 48.5 kb phage genome. Furthermore, producing appreciable quantities of 
recombinant DNA requires packaging the λ-DNA into phage particles, several rounds of 
viral amplification, and infection on an E. coli host with high-titer λ-phage prior to DNA 
purification.  
 Here, we developed a method for rapidly modifying and purifying recombinant λ-
phage DNA. We used in vivo recombineering to target any segment of the phage genome, 
abrogating the need for restriction sites and ligation. Using this approach, we develop a 
molecular toolkit for inserting exogenous DNA sequences into the λ-phage genome with 
>90% efficiency. I demonstrate a strategy for inserting non-replicative extrahelical DNA 
structures at these sites. I explore the utility of these DNA structures by demonstrating site-
specific loading of yPCNA by the clamp-loader complex Replication Factor C (RFC). Our 
results show that yPCNA can be loaded on both flaps and a (CAG)13 triplet nucleotide 
repeat (TNR). Surprisingly, yPCNA remains trapped within the (CAG)13 repeat, adding 
further support to a model that suggests yPCNA participates in TNR expansion via 
illegitimate activation of the DNA mismatch repair machinery (225–227). In sum, we 
anticipate that this molecular toolkit will be broadly useful for both ensemble and single-
molecule studies that require site-specific modification of long DNA substrates. 
 
Materials and Methods 
 
Preparation of λ-phage lysogens for insertion of extrahelical structures 
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 The E.coli lysogen used to insert flap- or (CAG)13-containing structures was 
generated by Red-based in vivo recombination (199). First, lysogens containing wild-type 
λ-phage DNA (IF189) were transformed with pKD78, which harbors the Red 
recombineering system under the control of an arabinose-inducible promoter (228). The 
insertion DNA including a nicking cassette were PCR amplified from the helper plasmid 
using Taq DNA polymerase (NEB# M0320S). The gel-extracted PCR products was re-
suspended in Milli-Q water to a final concentration of 100-150 µg µL-1 and used as the 
targeting DNA for the recombineering reaction. Fresh electrocompetent cells were 
prepared for every recombineering reaction. A 5 mL LB culture of strain IF189 
transformed with pKD78 was grown overnight at 30°C in the presence of 10 µg µL-1 
chloramphenicol. The following day, 350 µL of cells were used to inoculate a fresh 35 mL 
culture of LB containing the same concentration of antibiotic. When the cells reached an 
O.D.600 ~0.5, the Red recombinase system was induced by adding 2% L-arabinose 
(GoldBio) and incubated for an additional 1 hour at 30˚C. Cells were harvested at 4,500 
RCF for 7 min, washed three times in ice-cold Milli-Q H2O, and finally resuspended in 
200 µL of H2O (229). For recombineering, 50-150 ng of targeting DNA was electroporated 
at 18 kV cm-1 in 0.1 cm cuvettes using a micropulser (Biorad #165-210). Cells were 
immediately resuspended in 1 mL of SOC and then transferred to culture tubes containing 
10 mL LB broth. After 4 hours outgrowth at 30°C, 100 µL of the culture was plated onto 
LB agar plates containing either 30 µg mL-1 carbenicillin or 30 µg mL-1 kanamycin. 
Colonies were checked for successful incorporation of recombinant DNA via colony PCR. 
 
Purifying Phage DNA from lysogens 
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 A single lysogenic colony was grown in 50 mL of LB broth with the appropriate 
antibiotic overnight at 30°C. 5 mL of this starter culture was used to inoculate 500 mL of 
LB the following morning. When the O.D.600 reaches ~0.6, the temperature was rapidly 
raised to 42°C in a water bath. The culture was placed at 45°C in a shaking incubator for 
15 minutes and then transferred to a 37°C for two hours. To liberate the phage particles, 
cells were harvested by centrifugation at 3,000 RCF for 30 minutes and lysed via re-
suspension in 10 mL of SM buffer (50 mM Tris-HCl [pH 7.5], 100 mM NaCl, 8 mM 
MgSO4) + 2% chloroform, and rotated at 37°C for 30 min. A subsequent 1 hour incubation 
with 50 ng µL-1 DNaseI (Sigma# D2821) and 30 ng µL-1 RNaseA (Sigma# R6513) 
degraded the bacterial genomic DNA and RNA. The clarified lysate, containing soluble 
phage capsids, was obtained by centrifugation for 15 minutes at 6,000 RCF and 4°C, and 
further diluted with 40 mL of SM buffer. Phage capsids were precipitated by incubating 
for 1 hour with 10 mL ice-cold buffer L2 (30% PEG 6000, 3M NaCl) and then harvest by 
centrifugation at 10,000 RCF for 10 minutes at 4°C. The phage pellet was washed with 1 
mL of buffer L3 (100 mM Tris-HCl [pH 7.5], 100 mM NaCl, 25 mM EDTA) and then re-
suspended with 3 mL of buffer L3, followed by an equal volume of buffer L4 (4% SDS). 
The phage capsid proteins were further digested by incubation with 100 ng µL-1 of 
proteinase K for 1 hour at 55°C. 3 mL buffer L5 (3 M potassium acetate [pH 7.5]) was 
added, and the cloudy solution was clarified by centrifugation at 15,000 RCF for 30 
minutes at 4°C. The soluble phage DNA was passed over a pre-equilibrated Qiagen tip-
500 column (Qiagen #10262), washed with buffer QC (1.0 M NaCl, 50mM MOPS [pH 
7.0], 15% isopropanol) and eluted with 15 mL buffer QF (1.25 M NaCl, 50 mM Tris [pH 
	
88	
8.5], 15% isopropanol). Finally, the DNA was precipitated with the addition of 10.5 mL of 
100% isopropanol, rinsed in 70% ethanol and re-dissolved in TE buffer (10 mM Tris-HCl 
[pH 8.0], 1 mM EDTA) to a final DNA concentration of 200-500 ng µL-1. We routinely 
obtained ~250 µg of pure λ-DNA from a single purification. 
 
Inserting synthetic oligonucleotides into λ-DNA 
 25 µg of the DNA was incubated with 150 U of Nt.BspQI (NEB) in a 250 µL 
reaction with 1X buffer 3.1 at 55°C for 1 hour. The reaction was halted with 1 U of 
proteinase K (NEB #P8107S) for 1 hour at 55°C. The nicked DNA was mixed with a 100-
fold molar excess of the desired insert oligo (AD006 for 5’-flap, YK105 for (CAG)13, 
MB32 for mock insert, Table 4.1), along with a 10-fold excess of cosL and cosR-
complementary oligos (IF003 and IF004 for cosL à cosR, IF001 and IF002 for cosR à 
cosL, Table 4.1). The solution was heated to 70˚C for 15 minutes followed by slow cooling 
to 15°C in a thermocycler at a rate of -0.5°C min-1. The annealed mixture was 
supplemented with 6000 U of T4 DNA ligase (NEB#M0202L) and 1 mM ATP and further 
incubated overnight at room temperature in a final reaction volume of 300 µL. A 50 µL 
aliquot was taken for alkaline agarose gel and restriction enzyme digest analysis. The 
remaining 250 µL was supplemented with high salt (1M NaCl) and then passed through a 
120 mL Sephacryl S-1000 column (GE # 17-0476-01), in TE running buffer (10 mM Tris-
HCl [pH 8.0], 1 mM EDTA) plus 150mM NaCl, to separate the modified λ DNA from 
excess oligos and enzymes (Figure 4.1C).  
 
Purification of S. cerevisiae Proliferating Cell Nuclear Antigen (yPCNA) 
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 A plasmid expressing Saccharomyces cerevisiae His6-PCNA was kindly provided 
by Francisco Blanco(230). A triple FLAG epitope was introduced at the N-terminus via 
inverse PCR mutagenesis (NEB) using primers YK_PCNA01 and YK_PCNA02 (see 
Table 4.1) to generate pIF105. pIF105 was transformed into BL21(DE3) codon plus RIL 
cells. A colony was inoculated into 30 mL LB with 50 µg mL-1 kanamycin and 34 µg mL-
1 chloramphenicol, and grown overnight at 37°C. Ten mL of the overnight culture were 
seeded into 1 L LB and grown in the presence of both antibiotics. When the culture reached 
an OD600~0.5, 0.8 mM IPTG was added and induction continued at 37°C for 4 hours. Cells 
were harvested by centrifugation at 3,000 RCF for 10 minutes, and resuspended in 50mL 
lysis buffer (50 mM Tris-HCl pH 7.6, 150 mM NaCl, 0.5 mM TECP, 10% (v/v) glycerol) 
with 1x HALT protease inhibitor. Cells were lysed by sonication on ice and centrifuged at 
95,000 RCF for 30 minutes. Imidazole was added to the supernatant to a final concentration 
of 30 mM. A 5 mL HisTrap HP column (GE Healthcare) was pre-equilibrated with 50 mL 
lysis buffer and the lysate was loaded onto the column and washed with 50 mL of Ni-buffer 
(50 mM Tris-HCl [pH 7.6], 150 mM NaCl, 10% glycerol (v/v), 30 mM imidazole). PCNA 
was eluted with a ~110 mL gradient to Ni-buffer + 500 mM imidazole over 120 minutes. 
PCNA-containing fractions were identified via 12% SDS-PAGE, dialyzed into storage 
buffer (20 mM Tris-HCl [pH 7.6], 100 mM NaCl, 10% (v/v) glycerol, 1 mM DTT) and 
concentrated using a centrifugal filter (10 kDa Amicon, Millipore). Small aliquots were 
frozen in liquid nitrogen and stored at -80°C. 
 
Purification of S. cerevisiae Replication Factor C (yRFC) 
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 The plasmids pLant2b-RFC-AE and pET11-RFC-BCD were kindly provided by 
Manju Hingorani(231). The two plasmids were co-transformed into BL21(DE3) 
ArcticExpress cells (Agilent). A single colony was inoculated into 680 µL of LB and grown 
overnight at 37˚C. 200 µL of these cells were then seeded into 2 L LB with 50 µg mL-1 
kanamycin and 50 µg mL-1 carbenicillin. The culture was grown at 30°C to an OD600~0.6, 
cooled on ice with swirling to 16°C and induced with 0.5 mM IPTG. Induction continued 
for 16 hours at 12°C. Cells were harvested by centrifuging for 15 minutes (3,300 RCF at 
4°C) and resuspended in 20 mL of lysis buffer (30 mM HEPES [pH 7.5], 0.25 mM EDTA, 
5% (v/v) glycerol). The resuspended cell paste was either frozen in liquid nitrogen and 
stored at -80°C, or prepared for lysis by adding 250 mM NaCl, 1 mM 
phenylmethanesulfonyl fluoride (PMSF, Sigma-Aldrich), and 1x HALT protease inhibitor 
(Thermo-Fisher). Cells were lysed in a homogenizer (Avestin), and centrifuged (140,000 
RCF, at 4°C) for 35 minutes. A home-made 7 mL SP FF column (resin from GE Healthcare) 
was equilibrated with 35 mL of buffer A (30 mM HEPES [pH 7.5], 0.25 mM EDTA, 5% 
(v/v) glycerol) + 200 mM NaCl and the clarified lysate was loaded onto the equilibrated 
column at 0.5 mL min-1. The column was then washed with 35 mL of buffer A + 250 mM 
NaCl and the protein was eluted with a 100 mL gradient to buffer B (30 mM HEPES [pH 
7.5], 0.25 mM EDTA, 5% (v/v) glycerol, 1 M NaCl) at 1 mL min-1. yRFC-containing 
fractions were pooled and developed through a 1 mL Q HP column (GE Healthcare) pre-
equilibrated with buffer A + 100 mM NaCl. The combined sample from the SP column 
was loaded onto the Q column at a rate of 0.7 mL min-1. The column was washed with 10 
mL of buffer A + 110 mM NaCl at 0.8 mL min-1, and then eluted with an 18 mL gradient 
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into buffer B at 0.8 mL min-1. The eluted Q column fractions were analyzed on a 10% SDS-
PAGE gel, and the fractions containing yRFC were combined, frozen in liquid nitrogen, 
and stored at -80°C. The yRFC concentration was determined by comparison to a BSA 
titration curve using SDS-PAGE. 






























** The nucleotides for 5’-ssDNA flap or (CAG)13 are shown in bold. 




yRFC loads yPCNA on λ-DNA containing various extrahelical DNA structures 
 To investigate S. cerevisiae PCNA (yPCNA) dynamics on modified λ-DNA 
containing a abnormal DNA structure such as Flap or TNR-mediated step loop, I tested 
how yRFC loads yPCNA on various DNA structures. RFC loads PCNA upon ATP 
hydrolysis by opening and closing the clamp ring. Although RFC preferentially loads 
PCNA on primer-template junctions, it can also load on nonspecific homoduplex dsDNA. 
RFC has also been proposed to load PCNA on extrahelical triplet nucleotide repeats (TNR), 
ultimately driving TNR expansion. However, most previous biochemical studies have used 
a truncated RFCΔN that lacks a DNA-binding patch in Rfc1 subunit(232). Because the N-
terminal region of Rfc1 is responsible for binding dsDNA non-specifically, people have 
avoided the motif complicating ensemble experiments. Thus, I investigated yPCNA 
loading with the more physiologically relevant full-length (wild-type; wt) yRFC.  
 To test the relative specificity of yPCNA loading onto DNA containing a 30-nt 5’-
ssDNA flap, a (CAG)13 repeat, and homoduplex dsDNA, I first inserted each of the 
structure at site A on λ-DNA (Figure 4.2A). For visualization of yPCNA, I purified yPCNA 
with a triple FLAG epitope tag on the N-terminus, which is far away from the DNA binding 
site(233, 234). To capture the yRFC-yPCNA complex at the loading site, I used the slowly 
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hydrolyzing ATPγS in the pre-incubation and loading reactions for the two proteins. 
ATPγS prevents RFC from closing and releasing PCNA ring, so I can observe the binding 
sites of PCNA trapped by RFC. yPCNA was fluorescently labeled in situ with α-FLAG 
Qdots, as described for the single-molecule study of human PCNA (235). I titrated the 
yRFC(ATPγS)-yPCNA complex concentration to see about one PCNA molecule per DNA. 
I confirmed that the yPCNA loading on DNA was RFC- and the nucleotide- dependent.  
 I visualized that yRFC preferentially loads yPCNA at the 5’-ssDNA flap relative to 
homoduplex regions on DNA, which agrees well with prior studies (Figure 4.2B) (235, 
236). Turning off buffer flow retracted both the DNA and yPCNA to the Cr barrier, 
confirming that yPCNA was bound on the DNA (Figure 4.2B, bottom). I also observed 
mild enrichment of yPCNA at a (CAG)13 repeat relative to homoduplex DNA (Figure 
4.2C). To better characterize the binding efficiency on these structures, I measured the 
relative enrichment of yPCNA in a 5 kb window spanning the replaced region (site A) for 
the three recombinant DNA substrates (Figure 4.2C). The window was selected because it 
captures ~ 99% (~3 standard deviations of the Gaussian fit in Figure 4.2C, top) of all site-
specifically bound yPCNA molecules. Loading at the 5’-ssDNA flap shows 2.7-fold 
enrichment over homoduplex DNA, whereas loading at the (CAG)13 was 1.5-fold higher 
than homoduplex DNA (Figure 4.2D).  
 
RFC loads PCNA preferentially at a trinucleotide repeat structure 
 Because the enrichment at (CAG)13 was very modest, I also tested the yPCNA 
binding to (CAG)13 inserted at site B and at site A with a flipped tethering geometry (Figure 
4.3). The distribution of yPCNA loading on the DNA showed mild preference at the 
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expected (CAG)13 locus in all three DNA substrates (Figure 4.3B). Moreover, the 
enrichment was statistically significant (p-value: 1 x 10-4) when compared against all 
possible 5 kb windows across the entire 48.5 kb DNA (Figure 4.4). These data demonstrate 
that wt yRFC has a mild preference for yPCNA loading onto (CAG)13 repeat relative to 
homoduplex DNA.  
 
PCNA freely diffuses on DNA predominantly by 1D sliding   
 PCNA has a 3.4 nm-diameter inner opening that is larger than the width of B-form 
DNA (233, 234). This inner opening facilitates sliding past small mismatches and bulges, 
but may be blocked by larger extrahelical structures (236). To visually test this hypothesis, 
I used double-tethered DNA curtains to observe yPCNA diffusion on various DNA 
substrate (Figure 4.5A). For these experiments, I used ATP to load yPCNA by yRFC so 
that RFC can hydrolyze ATP to catalyze the closing of the yPCNA ring and release of itself 
from DNA. To ensure complete yRFC removal from DNA, I washed the flowcells with 
BSA buffer containing 300 mM NaCl. Following yRFC removal, the yPCNA molecules 
freely diffused over the entire length of the double-tethered DNA curtains (Figure 4.5).  
 Ring-like proteins can diffuse on DNA via a combination of two different modes: 
1D sliding and/ or hopping. During 1D sliding, the protein tracks the helical backbone of 
the dsDNA. In contrast, hopping is characterized by a series of correlated microscopic 
dissociation and re-association events. To differentiate between sliding and hopping, I 
measured yPCNA diffusion coefficients at increasing ionic strengths (Figure 4.6). A higher 
ionic strength increases electrostatic screening between a protein and DNA, reducing the 
fraction of time that a protein is in contact with the DNA. This results in increased diffusion 
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coefficients at higher ionic strengths. yPCNA diffusion was weakly dependent on the ionic 
strength, in agreement with a previous study with hPCNA (235). The ionic strength-
dependent change in diffusion coefficients was 0.33 ± 0.04 µm2 sec-1 mM-1 and 0.25 ± 0.06 
µm2 sec-1 mM-1 for hPCNA and yPCNA, respectively (Figure 4.6). This indicates that 
yPCNA as well as hPCNA diffuses predominantly by 1D sliding along the helical pitch of 
the DNA backbone. 
      
PCNA diffusion is largely blocked by extrahelical structures on λ-DNA 
I next monitored yPCNA diffusion on DNA containing a 5’-ssDNA flap or a (CAG)13 
repeat (Figure 4.6). yPCNA can approach the secondary structure from one of two 
orientations: (i) in the cosL à cosR direction, yPCNA encounters a 4-nt ssDNA gap prior 
to the flap structure and (ii) in the cosR à cosL direction, yPCNA encounters the 5’-T30 
tail. I observed that out of 40 yPCNA molecules, 90% (N=36/40) were blocked by the flap 
in either orientation (N=18 for cosL à cosR and N=18 for cosR à cosL). The remaining 
molecules were either captured at the nicing cassette (5%, N=2/40) or directly bypassed 
(5%, N=2/40) the flap structure. This observation may result from incomplete re-ligation 
of the oligos annealed at this site. These data show that the flap is too large to be 
accommodated within the yPCNA ring. The (CAG)13 repeat also blocked yPCNA diffusion 
from either direction. Remarkably, I also observed that 30% (N=11/36) of the yPCNA 
molecules loaded directly at the (CAG)13 were stationary (Figure 4.6C). To further verify 
whether (CAG)13 structure actually capture yPCNA, I tested the DNA harboring the same 
TNR repeat at site B as well as flipped DNA with (CAG)13 at site A (Figure 4.7A-B). The 
distribution of diffusing, stationary, and (CAG)13-blocked yPCNAs was statistically 
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indistinguishable across all three (CAG)13-containing DNA (Figure 4.7C). I conclude that 
yPCNA diffusion is blocked by large extrahelical structures and that yRFC loads yPCNA 
on the (CAG)13 repeat. This result is consistent with a mechanism where TNR-bound 




Using nickase-based strategy for incorporating extrahelical structures at defined positions 
along the DNA duplex, I demonstrated that wtRFC preferentially loads yPCNA on 5’-
ssDNA flaps and (CAG)13 repeats relative to homoduplex DNA. yPCNA can diffuse on 
homoduplex DNA but is blocked by both a (CAG)13 repeat and a 30-nt (T)30 ssDNA flap. 
These observations suggest that PCNA cannot simultaneously accommodate both the 
homoduplex DNA track (2 nm diameter for B-form) and the additional DNA structures 
within its inner ring. Molecular dynamics simulations and ensemble biochemical studies 
suggest that homopolymeric poly-T oligonucleotides occupy an ensemble of extended 
structures (e.g., 2.7 nm end-to-end distance for a (T)12 oligonucleotide; we used a 
(T)30)(237). Similarly, structural and biochemical studies have established that relatively 
short (CNG)n=3-10 repeats are in a hairpin-stem structure with mismatched A•A base pairs 
that are flanked by two Watson-Crick G•C base pairs (238–241). However, above a critical 
threshold of trinucleotide repeats, (CNG)n>11, the oligonucleotide transitions from a simple 
hairpin–stem model to bis- (or multi-branched) hairpin-like structures and bulged out 
ssDNA loops (239, 241). This dynamic, multi-branched structure likely explains why a 
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(CAG)13 repeat acts as both a loading site and a barrier to PCNA diffusion. Finally, yPCNA 
that is directly loaded onto the (CAG)13 is trapped at the lesion. These results shed light on 
PCNA diffusion dynamics and further highlight the utility of this molecular toolkit for both 







Figure 4.1: Modification of λ-DNA at unique positions. (A) Two disposable segments 
were chosen to modify the λ-DNA. These regions are 21.3 kb and 33.5 kb away from cosL 
(designated A and B respectively). (B) Schematic of the Red-based recombineering. A 
designed insert DNA containing appropriate homology replaced the original λ-DNA via 
Red products. (C) Schematic of nicking enzyme-mediated insertion of a synthetic 






Figure 4.2: yRFC loads yPCNA onto various extrahelical structures. (A) Schematic of 
a single-tethered DNA curtain assay. DNA molecules (green) are stretched by buffer flow. 
One of the insertion sites (site A) is indicated in blue. (B) Fluorescent images of yPCNA 
on λ-DNA containing a 5’-ssDNA flap inserted at site A with buffer flow (top) and without 
flow (bottom). DNA is stained with YOYO-1 (green) and yPCNA is labeled with anti-
FLAG antibody and QDs (magenta). Stopping buffer flow retracts both yPCNA and DNA 
to the Cr barrier, confirming that yPCNA is bound on the DNA, not on the surface (bottom 
panel). (C) Binding distribution histogram of yPCNA/yRFC on λ-DNA containing a 5’-
ssDNA flap (top), (CAG)13 (middle), and homoduplex (bottom) at site A. Red line is the 
fit to a Gaussian distribution (center = 21.2 kb ± 1.4 kb). Gray box indicates a 5 kb window 
that captures 99% of all yPCNAs at site A. (D) The mean number of yPCNA molecules 
loaded on the site A (within the gray box). Error bars is generated by the bootstrap 





Figure 4.3: yRFC has a mild preference for yPCNA loading at (CAG)13 repeats 
relative to homoduplex dsDNA regions. (A) To determine whether the mild yPCNA 
loading at (CAG)13 structure is authentic observation, the λ-DNA substrate was divided 
into eight 5 kb-wide windows (dashed lines). The first window (dark gray) is partially 
obstructed by the Cr barriers. Windows containing the (CAG)13 repeat are shown in pink. 
(B) Normalized binding distribution of yPCNA/yRFC complexes on three DNA substrates 
containing (CAG)13. The binding histograms were also divided into eight 5 kb-wide 
windows. The first window partially obscured by the Cr barrier is shown in dark gray, the 
target-containing window is pink, and other homoduplex DNA regions are gray. The 
(CAG)13-containing windows (pink) show mild preference for PCNA loading for all three 






Figure 4.4: Statistical analysis of the mild preference for yPCNA loading at (CAG)13 
repeat on the three DNA substrates. Based on the data shown in Figure 4.3, A two-tailed 
t-test was used to compare the groupings of three windows—including the three (CAG)13-
containing window—against all homoduplex DNA windows. A normalized histogram of 
all two-tailed t-tests comparing the mean yPCNA occupancy of all three-window 
combinations relative to the mean yPCNA occupancy in all windows containing 
homoduplex DNA. Over 97% of the tests showed no significance (p-value > 0.05). The 
highest p-values are shown in the inset and include the (CAG)13-containing sites, as well 
as the partially obstructed first window. This is because the Cr barrier causes the first 
window to underestimates yPCNA binding. All p-values in the p=0.001-0.05 range were 










Figure 4.5: Characterization of yPCNA diffusion on homoduplex λ-DNA. (A) 
Schematic of double-tethered DNA curtains for observing PCNA diffusion on DNA. (B) 
A kymograph of yPCNA freely diffusing on λ-DNA. (C) Representative single-molecule 
traces of the position of individual yPCNA molecules (shown in three different colors) on 
double-tethered DNA curtains at a total ionic strength I = 176 mM. (D) Mean squared 
displacement (MSD) of each of the molecules in (C). The MSDs are fit to a line, and the 
slopes are used to calculate the one-dimensional diffusion coefficients (solid lines). (E) 
Mean yPCNA diffusion coefficients as a function of the ionic strengths (error bars: S.E.M; 
to N = 30, 29, 29, 31 for 76 mM, 176 mM, 326 mM, and 525 mM ionic strengths, 
respectively). The red line indicates a linear fit through the data with a slope of 0.25 ± 0.06 
µm2 (sec mM)-1. The error in the slope represents the standard error of the fit. These results 
are consistent with a single-molecule study that looked at hPCNA diffusion on homoduplex 
DNA (243). Diffusion of both hPCNA and yPCNA was weakly dependent on the ionic 
strength (0.33 ± 0.04 µm2 sec-1 mM-1 and 0.25 ± 0.06 µm2 sec-1 mM-1 for hPCNA and 





Figure 4.6: PCNA diffusion on λ-DNA containing various extrahelical structures. 
Kymograph of diffusing PCNA molecule on DNA substrates with (A) a 5’-ssDNA flap, 
(B) a (CAG)13 repeat, or (C) mock-treated homoduplex DNA. The characteristic changes in 
diffusion behavior of PCNA are indicated with arrows, and the dashed lines indicate site 
A. (D) Percentage of molecules showing either bypass, blocked, or captured behavior at 
site A. At least 35 DNA molecules were analyzed and classified into each of three 






Figure 4.7: yPCNA diffusion on λ-DNA containing (CAG)13 repeat at site A and B. 
Representative kymographs of diffusing yPCNA molecules on DNA having (CAG)13 at 
flipped A (A) or site B (B). The characteristic changes in diffusion behavior of yPCNA at 
(CAG)13 sites are shown with arrows, and each dashed line indicates the position of a 
(CAG)13 repeat. (C) Percentage of molecules showing either bypass, blocked, or captured 
behavior at (CAG)13 insert on λ-DNA. At least 35 DNA molecules were analyzed and 
classified into each of three categories (N=36, 62, and 46 for site A (from Figure 4B), 











Prion-like domains (PrLD) are a subset of intrinsically disordered regions (IDR) that are 
characterized by low sequence complexity such as glutamine/asparagine repeats (244). 
Such sequence features are found in many prions, and the web-based PrLD prediction 
algorithm, PLAAC, is routinely used to identify PrLDs by these sequence features (244, 
245). Approximately 1.2% of protein-coding genes are comprised of PrLD, and about 20% 
of PrLD-containing DNA binding proteins have known or predicted transcription factor 
activity (244, 245). Many PrLD-containing TFs act as hubs in regulatory protein networks 
and can interact with multiple partners via PrLDs (4, 12, 110, 111). Importantly, the 
sequence properties of PrLDs in non-prion proteins confer the ability to self-associate and 
form higher-order assemblies such as gel-like structures (246). The functional role of PrLD 
in protein assembly has been recently described in many cellular pathways, including 
RNA-binding proteins, membrane receptors, and chaperone proteins (21, 244, 247, 248). 
 Super-enhancers (SE) are a cluster of enhancers that drive robust gene expressions 
controlling cell identity and development (116, 249). Recent studies have shown that a 
high-density of transcriptional coactivators, Mediator, and RNA polymerase II are all 
located at the enhancer domain (112, 250). Interestingly, IDRs concentrated the 
transcription apparatus in cells and in nuclear extract (112). IDRs provide the biophysical 
property necessary to induce molecules to separate into dense and dilute phases (112). This 
phase separation behavior of transcriptional regulators containing IDRs suggested a model 
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where transcription machinery locally concentrate all cis- and trans-regulatory elements 
and facilitate gene transcription activity at SEs (112, 115). However, the phase separation 
of transcription apparatus on DNA has not been demonstrated at the molecular level. 
Furthermore, transcription factors (TF) containing PrLDs, a subset of IDRs, have not been 
explored in this context. Here, I study the role of PrLDs in TF phase separation on DNA 
using the TF network controlling cell identity in C. albicans. 
 C. albicans is a fungal pathogen that reversibly switches between two cell types, 
‘white’ and ‘opaque’ (Figure 5.1A). White cells are more virulent in systemic infections 
whereas opaque cells are the mating-competent form of C. albicans (251). Each type can 
be inherited and maintained across many generations (118). Efg1 is a master transcription 
factor that is critical for switching from the opaque to white cell type (Figure 5.1B). Efg1 
is also important in transcriptional networks controlling hyphal and biofilm formation, 
which is required for virulence and disease progression (121, 123, 124). Subsequent studies 
have identified other TFs in the white-opaque circuit, including Wor1, Wor4, and Czf1 
(118, 120, 252). Although it is established that these master TFs create a network to control 
the cell type switching, the mechanism by which these proteins act together is unclear. 
 Efg1 contains a helix-loop-helix motif that is important for sequence-specific DNA 
binding (Figure 5.1C) (121, 253). Efg1 also contains extensive polyglutamine (polyQ) 
stretches at the N- and C-terminal regions (121) that are predicted to be disordered PrLDs 
by the PLAAC algorithm (Figure 5.1C) (245). My collaborator, Dr. Corey Frazer at Brown 
University has observed that Efg1 forms liquid-like droplets that undergo fission and fusion 
at above a threshold concentration in vitro (in preparation). Deletion of the PrLD of Efg1 
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eliminated droplet-like properties, and failed to induce cell type switching (unpublished 
data). Here, I investigate how the PrLD-containing TF behave on DNA. I demonstrate that 
i) Efg1 condense DNA in a PrLD- and concentration-dependent manner, ii) Efg1 can 
compact nucleosome-containing DNA, iii) Efg1 can recruit other master PrLD-containing 
TFs on DNA independent of their DNA-binding domains. This supports the hypothesis 
that such master TFs phase separate in a PrLD-dependent manner on DNA and create a 
condensed transcriptional apparatus that can serve as hub for recruitment of transcriptional 
coactivators and RNA polymerase II.  
 
Materials and Methods 
 
Purification of Efg1 and TEV Protease: Wild-type Efg1 was overexpressed in BL21 (DE3) 
cells, and purified from Ni-NTA resin and Superdex-200. All variant Efg1 proteins were 
provided by the Bennet lab (Brown Univ.). TEV Protease was purified from plasmid 
pRK793 cotransformed with pRIL (pIF 189) into BL21 (DE3) cells as previously described 
(Tropea et al., 2009). pRK793 was a gift from David Waugh (Addgene plasmid # 8827).  
 
Imaging DNA condensation by TFs: All single-molecule experiments were conducted in 
imaging buffer (40 mM Tris-HCl pH 8.0, 1 mM MgCl2, 0.2 mg mL-1 BSA, 50 mM NaCl, 
1 mM DTT). DNA contraction was observed via a fluorescent signal on the Dig-labeled 
DNA ends. These ends were fluorescently labeled by injecting 100 µL of 10 nM α-Dig 
antibodies (Life Tech, 9H27L19) and 700 µL of 2 nM α-rabbit antibody-conjugated 
quantum dots (QDs) (Life Tech, Q-11461MP) into the flowcell. After labeling dig-ends of 
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DNA, the single-tethered DNA molecules were elongated by consistently applying 450 µL 
min-1 flow rate. To see TFs-driven DNA condensation, 10 – 300 nM of the indicated TF 
was incubated with 100 µg µL-1 of TEV protease in 1 mL imaging buffer for 5 minutes at 
room temperature, then injected into the flowcell at a flow rate of 450 µL min-1. The 
position of QD-labeled DNA ends was recorded for up to 20 minutes. 
 
Observing TF recruitment via the prion-like domains: Double-tethered DNA curtains were 
used to determine whether TFs can interact via their prion-like domains. In this assay, the 
DNA is captured and extended between a chromium barrier and an α-Dig antibody 
deposited on a chromium pedestal(254). Keeping the DNA fully extended prevents TF-
driven compaction. Next, 300 nM of 6xHis–MBP–Efg1 was first injected without TEV 
cleavage, then 300 nM GFP-Efg1∆DBD or GFP-Wor1∆DBD incubated with 100 µg/µL 




Efg1 condenses DNA in a concentration-dependent manner 
 Based on our observation that Efg1 phase separates in vitro and forms liquid-like 
droplets, I reasoned that self-assembly of DNA-bound TFs will lead to contraction of 
extended DNA molecules. I used high-throughput DNA curtains to test this hypothesis on 
single molecules of DNA (Figure 5.3A). To visualize TF-induced DNA contraction, I used 
the single-tethered DNA curtains where the DNA was biotinylated on one end and labeled 
with a fluorescent antibody on the opposite end (Figure 5.3A). Efg1 was used as a 
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representative TF in most DNA curtain experiments. To test whether Efg1 condenses DNA, 
I first pre-incubated the TF with TEV protease to remove the MBP and injected the mixture 
into the flowcell containing pre-assembled DNA curtains. Efg1 rapidly contracted the 
DNA as observed by the retraction of the fluorescent DNA end towards the biotinylated 
tether point (Figure 5.3B, top). I could measure the rate and length of DNA condensation 
by using particle tracking of the fluorescent DNA ends. The rate of DNA contraction was 
Efg1 concentration-dependent, with no contraction at 10 nM Efg1 (N=27 DNA molecules) 
and rapid contraction of 4 ± 1.4 kb s-1 at 300 nM Efg1 (Figure 5.3C). Efg1 contracted most 
DNA molecules nearly completely (to the microfabricated barrier) when using both the 
high (300 nM) and intermediate (50 nM) Efg1 concentration (Figure 5.3D). In contrast, 
MBP-Efg1 (without treatment with TEV protease) significantly slowed the DNA 
contraction rate and reduced the overall contraction length, indicating that the MBP largely 
blocks Efg1 self-assembly on DNA (Figure 5.3B-D). This is consistent with our 
collaborator’s observation that MBP-Efg1 does not phase separate in vitro (unpublished 
data). 
 
Prion-like domains are required for DNA condensation 
 Next, I tested whether the DNA condensation requires both the Efg1 DNA binding 
domain as well as the PrLD. For this purpose, I used two GFP-tagged Efg1 constructs that 
delete either the DNA binding domain (DBD) or the PrLD. As expected, injecting GFP-
Efg1 that lacked the PrLD (GFP-Efg1ΔPrLD) still retained robust DNA-binding activity 
and could completely coat the DNA substrate (Figure 5.4A, top and middle). Also, 
injecting GFP-Efg1 that lacked the DBD neither condense nor bound the DNA (Figure 
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5.4A, bottom). These data demonstrate that the Efg1-driven DNA condensation requires 
both the PrLD self-assembly and DBD domains. 
 I next sought to determine whether the PrLDs are sufficient for multivalent TF 
interactions on DNA. In this assay, the DNA molecules were tethered by both DNA ends 
to inhibit Efg1-driven DNA condensation (Figure 5.4B). Next, Efg1 was injected into the 
flowcell, followed by GFP-TF fusions that lack DNA-binding domains (GFP-Efg1ΔDBD 
or GFP-Wor1ΔDBD). Both GFP-Efg1ΔDBD and GFP-Wor1ΔDBD rapidly accumulated 
over the entire length of the double-tethered DNA molecules, indicating that these proteins 
were interacting with DNA-bound Efg1 via their PrLDs (Figure 5.4C).     
 
Nucleosome regulates DNA condensation by the transcription factors 
 In the cell, TFs must function in the context of chromatin. Thus, I assessed how 
nucleosomes regulate Efg1-induced DNA condensation (Figure 5.5A). For this assay, 
dense nucleosome arrays (>10 nucleosomes per DNA) were deposited on the DNA 
substrate via step-wise salt dialysis (132). Nucleosomes were visualized via a fluorescent 
antibody directed at an HA epitope on H2A, as described previously(50, 206). Efg1 still 
contracted the nucleosomal DNA substrates, but at a significantly slower rate than on naked 
DNA (Figure 5.5B–D). Interestingly, Efg1 contraction rates changed on single molecules 
and had frequent intermediate plateaus (Figure 5.5B). I thus reported the average 
contraction rate per molecule in Figure 5.5C. I reasoned that the reduced compaction rates 
may stem from nucleosomes acting as physical barriers for Efg1 binding. In support of this 
model, nucleosome-free DNA regions compacted more rapidly than nucleosome-dense 
regions of the same DNA substrate (arrows in Figure 5.5B). Thus, nucleosome density can 
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control local DNA compaction by TFs in vivo. Taken together, these data demonstrate that 
Efg1 condenses naked and nucleosome-coated DNA and that multiple TFs can be recruited 




SEs create a large enhancer domain mediated by a high-density of transcriptional regulators. 
This proposes a model where phase-separated transcriptional regulators form a 
concentrated apparatus to control gene expression (112, 115, 257). The phase-separated 
transcriptional coactivators and Mediator have been observed in vivo, and colocalize with 
RNA polymerase II (112, 250). However, no direct evidence of phase separation of TFs on 
DNA at a molecular level has been reported so far. Here, I used a single-molecule assay 
and a TF network controlling white-opaque switching in C. albicans as a case study. I 
demonstrated that master TFs containing PrLDs self-associate on DNA, which results in 
DNA condensation. The DNA compaction by Efg1, a TF responsible for white cell type 
and virulence in C. albicans, required both DNA binding and the PrLD. The presence of 
an MBP tag next to the N-terminal PrLD of Efg1 significantly inhibited the DNA 
condensation. These results support a model by which the multivalent interactions between 
PrLDs facilitate the phase separation of TFs on DNA and create the DNA-TFs condensates. 
I also show that DNA covered by one master TF can be also bound by other master TFs 
through PrLDs. I propose that the condensates made by one or multiple master TFs serve 
as a platform that recruits other multivalent coactivators and RNA polymerase II to create 
a bona fide active enhancer domain (258, 259).   
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 DNA is organized into chromatin, which influences transcriptional condensation 
by TFs in vivo. My single-molecule experiments with nucleosomal DNA show that the TF 
can condense DNA with nucleosomes, albeit at a slower rate and a lesser extent of 
condensation (Figure 5.4B–D). The DNA region with dense nucleosomes was condensed 
after the sparse nucleosomes region (Figure 5.4B). This is consistent with previous reports 
that nucleosomes represent a mechanical barrier to regulate gene expression, and that 
regulatory sequences including promoters are nucleosome-depleted to promote TF 
accessibility across eukaryotic species (260–262). Thus, I propose that nucleosomes are 
physical barriers for TF binding at SEs, and nucleosome-density regulates transcription 
activation by controlling the DNA-TFs condensation and/or condensate dissolution in vivo. 
 Efg1 is also an important factor in hyphal growth for biofilm formation and 
virulence by C. albicans (263, 264). The TFs controlling biofilm development in the 
species create an additional TF network containing Efg1 and factors different from those 
regulating white-opaque switching (263). Using PLAAC analysis, I found that most 
reported TFs in the biofilm network contain PrLDs including Tec1, Bcr1, Brg1, Not80. 
How does Efg1 distinctively interact with each networking PrLD-containing TFs? Whether 
these TFs condense nucleosomal DNA and form distinct condensates from the white-
opaque switching network are all interesting areas of future study with implications for 
how PrLDs modulate complex TF networks. 





Figure 5.1: Efg1, a major transcription factor in white-opaque switching network, has 
long PrLDs at N- and C-terminal regions. (A) Representative microscope images of C. 
albicans in the white (left) and opaque (right) cell type. (obtained from Bennett Lab in 
Brown Univ.) (B) A schematic model of transcriptional network controlling the white-
opaque cell type switching in C. albicans (122, 124). Efg1 is required to switch from 
opaque to and maintain white cell type (121). (C) Predicted PrLDs using PLAAC analysis 
(245). DNA-binding domain (DBD) is shown based on previous functional mapping of the 
Efg1 (121, 253). The locations of PrLDs are indicated in red in the graph and one-letter 
amino acid residues of Efg1. This analysis also predicted IDRs by FoldIndex (265), which 






Figure 5.2: Illustration of Efg1 constructs. (A) Wild-type Efg1 and other variants were 
purified with 6xHis- and MBP-tags at N-terminus of Efg1. GFP was used to visualize the 
variants in some assays. TEV cleavage site was added between the tags and the proteins of 
interest. (B) Purification scheme of Efg1 constructs. (C) 8% SDS-PAGE gel of all 4 







Figure 5.3: Efg1 condenses DNA in a TEV-cleavage and concentration dependent 
manner. (A) Schematic of the DNA curtains assay. DNA ends are fluorescently labeled 
with Qdot-conjugated α-Dig antibodies and dark Efg1 is injected into the flowcell while 
keeping the DNA extended via mild buffer flow. (B) A representative kymograph of 300 
nM Efg1 condensing naked DNA in the presence (top) and absence (bottom) of TEV 
protease. The time point when Efg1 is injected into the flowcell is indicated with yellow 
dashed lines. (C) Rate and (D) degree of DNA condensation expressed as a percent of the 
total DNA length in the presence and absence of nucleosomes at different Efg1 
concentrations. Boxplots indicate the median, 10th, and 90th percentiles of the distribution. 
P-values are obtained from K-S test: * P-values <0.05, ** P-value < 0.01, *** P-value < 







Figure 5.4: PrLD is required for the multivalent interaction of TFs. (A) top: An image 
of single-tethered DNA curtain after injecting 300 nM GFP-Efg1∆PrLD into the flowcell; 
A representative kymograph showing nearly stationary DNA ends (magenta) when 
injecting 300 nM Efg1∆PrLD (middle) or GFP-Efg1∆DBD (green, bottom). (B) An 
illustration and (C) fluorescent images demonstrating that DNA-bound Efg1 can recruit 
other TFs via prion-like domains. (B) DNA molecules are double-tethered to block the TF-
driven DNA condensation, and 300 nM wild-type (wt) Efg1 was first incubated with the 
DNA. Then, GFP-Efg1∆DBD or GFP-Wor1∆DBD was injected with TEV protease. (C) 
Kymographs showing recruitment of GFP-Efg1∆DBD (top) or GFP-Wor1∆DBD (bottom) 








Figure 5.5: Nucleosome regulates DNA condensation by Efg1. (A) Schematic of 
nucleosome-DNA condensation by TFs. (B) A kymograph of Efg1 condensing 
nucleosome-coated DNA. Nucleosomes are shown in green and the fluorescently labeled 
DNA end is in magenta. The time point when Efg1 is injected into the flowcell is indicated 
with yellow dashed lines. The protein traverses the flowcell for a few minutes as its 
concentration is diluted by constant buffer flow. The rate and extent of DNA condensation 
is measured by tracking the fluorescent DNA end. (C) Rate and (D) degree of naked and 
nucleosome DNA condensation expressed as a percent of the total DNA length in the 
presence and absence of nucleosomes at different Efg1 concentrations. Boxplots indicate 
the median, 10th, and 90th percentiles of the distribution. P-values are obtained from K-S 
test: * P-values <0.05, ** P-value < 0.01, *** P-value < 0.005, and **** P-value < 0.0001. 







Chapter 6.  Summary and Future Directions 
 
In this dissertation, I described how IDRs are critical for the proper regulation of DNA 
repair and transcription-associated proteins. To observe dynamic behavior of these proteins 
in a more physiological in vitro setting, I developed and characterized DNA curtains 
assembled with human nucleosomes (50) (Chapter 2). In Chapter 3, I discussed the detailed 
functions of IDRs in Mlh1-Pms1, a eukaryotic MMR protein. MMR proteins also have 
been implicated in TNR expansions in human neurodegenerative diseases (61, 71). In 
Chapter 4, I also showed that RFC loads PCNA, another essential MMR protein, on the 
extrahelical structure made by TNR sequences (130). Lastly, I described in Chapter 5 that 
IDRs in transcription factors lead to DNA condensation and that nucleosomes regulate this 
activity, which suggests the mechanism of SE formation.    
 
 IDRs in Mlh1-Pms1 are essential for efficient MMR in vivo (109). There are a few 
points to think about the mechanistic role of the IDR linkers. First, Mlh1-Pms1 IDRs could 
impact the interaction with other target proteins such as ExoI and PCNA. Mlh1 C-terminal 
domain has a site for interaction with the Mlh1 interacting protein box ((R/K)SK(Y/F)F 
motif) of ExoI, which is critical for ExoI-dependent MMR (266, 267). Also, a direct 
interaction between PCNA and Mlh1-Pms1 has been reported by gel filtration (268). 
Further structural studies are required to elucidate how the linkers are connected to the 
binding sites in Mlh1-Pms1 and how the binding of partners is influenced by the ATP-
induced change in linker conformations. Second, the IDRs also affect the Mlh1-Pms1 
endonuclease activity. Work described in this thesis shows that the IDRs also influenced 
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the endonuclease activity of Mlh1-Pms1 (Figure 3.6). Notably, the single-round nicking 
activity on circular DNA was unaffected while the multiple-round nickng was 
compromised for the DLDnull. The nicking activity requires ATP as well as PCNA (Figure 
3.6A). Direct AFM imaging of Mlh1-Pms1 showed ATP-dependent compaction of the 
complex and suggested a model of linker scrunching upon nucleotide binding (97). Based 
on these observations, the IDR linkers could mediate the allosteric regulation of the 
nucleolytic activity by ATP binding. The compromised nicking activity for DLDnull could 
be due to the altered ATP-induced linker rearrangement. This can be examined by directly 
observing the linker conformation using AFM or EM imaging. Alternatively, one can 
conduct FRET single-molecule experiments to determine the dynamic conformational 
movement of the IDR linkers with respect to the NTD ATPase and endonuclease domain 
of Mlh1-Pms1. Third, our data have suggested the role of Mlh1-Pms1 IDRs in facilitating 
diffusion on DNA (Figure 3.4). 1D diffusion of DNA-binding proteins is affected by 
several factors such as the ionic strength, DNA binding affinity, and friction between DNA 
and a moving protein (44, 53, 269). DNA binding affinity of DLDnull were unaffected 
(Figure 3.2) whereas the diffusion coefficients were significantly decreased compared to 
wild-type (Figure 3.3). Mlh1-Pms1 is thought to encircle DNA by binding through a 
positively-charged groove made under the dimerized N-terminal domains. Thus, I 
speculate that shortening the linkers could bring the N- and C-terminal domains closer and 
thereby lead to an increase in the translational friction between the protein and DNA 
increase.   
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 The IDR linkers of MutL homologs vary in length. For example, the prokaryotic 
MutL linkers (90 a.a.) are only half as long as that in Mlh1 (109, 270). Interestingly, the 
portion of disordered residues tends to be high in eukaryotic homologs and the duplicated 
gene Pms1 (Pms2 in human) (Figure 3.1). Moreover, the Mlh3 homolog also has a long 
IDR linker (117 a.a.) (189). Besides its roles in MMR, Mlh3 plays additional roles in 
meiotic recombination, and the Mlh1-Mlh3 complex also prefers specific DNA structures 
(189, 271). These observations are consistent with the proteomic analysis showing that 
IDRs are more common in eukaryotes than prokaryotes and that they tend to be prevalent 
in regulatory proteins that require sophisticated roles in complex protein networks (1, 2). 
It will be interesting to see how Mlh1-Mlh3 IDRs play roles in MMR and meiotic 
recombination. 
 MMR proteins function on chromatin, where nucleosomes are assembled. Recent 
studies have shown that the presence of nucleosomes compromises Msh2-6 binding and 
sliding activity, and histone chaperones such as CAF-1 regulate MMR efficiency in vitro 
(37, 272, 273). The question thus arises: how do MMR proteins locate their targets in the 
presence of nucleosomes in vivo? Guo-Min Li’s group suggested a model by which human 
Msh2-6 is recruited to chromatin before replication by directly binding trimethylated 
histone 3 at H3K36 (H3K36me3) via a Pro-Trp-Trp-Pro motif in the Msh6 domain (274, 
275). Nucleosomes are disassembled ahead of replication fork and the nucleosome-bound 
Msh2-6 is released to the free DNA in search of a lesion. This motif is not present in yeast 
Msh6. However, yeast Msh2-6 can be recruited to the replication fork through a PCNA-
interacting motif (PIP-box) (78, 276). Importantly, in vivo cell imaging with fluorescent 
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proteins in yeast revealed that Mlh1-Pms1 foci are formed later than Msh2-6 foci that 
colocalized with replication factories (78). Thus, it is likely that Mlh1-Pms1 find their 
target after nucleosomes are re-assembled behind the replication fork. I showed that Mlh1-
Pms1 loads onto nucleosomal DNA nonspecifically and bypasses nucleosomes during 1D 
diffusion (Chapter 3) (163, 277). I speculate that Mlh1-Pms1 is loaded on a DNA region 
distant from a mismatch. Mlh1-Pms1 efficiently bypasses the nucleosome barriers newly 
deposited behind the replication machinery (163, 277). Further study is required to see if 
other chromatin-associated factors such as histone modifications or remodelers promote 
Mlh1-Pms1 recruitment on chromatin. 
 Nucleosomes can serve as a beneficial controller for MMR. In a defined system 
that included both Mlh1-Pms1 and ExoI, nucleosomes could slightly promote MMR 
efficiency by inhibiting excess degradation of the discontinuous strand (272). I reason that 
the limited degradation in the presence of nucleosomes resulted from the combination of 
two mechanisms: i) nucleosomes blocked the degradation by ExoI (165) and ii) the reduced 
nucleosome bypass activity of Mlh1-Pms1 upon ATP binding (Figure 3.5) restrained the 
excision distance. How nucleosomes differentially influence the degradation of lesion-
containing DNA in ExoI-dependent and ExoI-independent pathway needs further 
investigation.     
 Msh2-3 differs from Msh2-6 with regards to its specificity for lesions, its target 
search mechanism, and its binding to PCNA and Mlh1-Pms1. However, how Msh2-3-
dependent MMR is differentially regulated on chromatin remains unclear. Which factor(s) 
influences Msh2-3 recruitment on chromatin and how does Msh2-3 regulate other MMR 
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factors? The physical interaction of Msh2-3 with PCNA through PIP-box is required for 
MMR, but the mechanism by which the two proteins influence MMR efficiency is not clear 
(278). PCNA acts as a signal for strand discrimination and activates Mlh1-Pms1 nicking 
activity, which is required for efficient MMR (279, 280). As shown in Msh2-6, Msh2-3 
might also inhibit PCNA unloading via PIP-box and maintain strand-specific MMR 
capability (280). Interestingly, unlike Msh2-6, Msh2-3 interacts with Mlh1-Pms1 through 
the same site that is required to bind PCNA (281). This suggests that Msh2-3-initiated 
MMR is fundamentally different from the Msh2-6-dependent pathway. It will be 
interesting to see how the competing Msh2-3 interaction between PCNA and Mlh1-Pms1 
influences the PCNA roles in strand-specific MMR and Mlh1-Pms1 activation.  
 
 MMR factors have been implicated in TNR instability that leads to many 
neurodegenerative diseases (62, 63, 71, 282). The length of TNR sequences is found to be 
expanded in the affected patients (61, 63). Expanded TNR in human disease form hairpin 
structure in vitro, which is thought to be bound by MMR factors and cause replication 
stalling (282, 283). In Chapter 4, I demonstrated the preferential loading of PCNA on 
(CAG)13 structure by RFC (Figure 4.2 and Figure 4.3) (225). The (CAG)13 repeat captured 
the loaded PCNA, preventing 1D diffusion by the sliding clamp (Figure 4.6). I propose the 
two following mechanisms of MMR-mediated TNR instability. First, many PCNA 
molecules can be loaded. The redundantly loaded PCNA molecules may recruit the 
partners including Msh2-3 and Mlh1-Pms1, leading to the formation of a large protein 
complex. The mass of MMR factors on a TNR site will result in replication stalling and 
slippage of the daughter strand over its template, leading to TNR instability (283). Another 
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possibility is that the captured PCNA on a TNR structure no longer plays a role in strand 
discrimination in the absence of DNA discontinuities (202, 280). Then, PCNA loading on 
a TNR may not direct Mlh1-Pms1 endonuclease on the TNR-containing strand and thus 
fail to remove the DNA lesion. This will allow DNA polymerase to use the TNR sequences 
as a template over and over, which can cause TNR expansion. It will be interesting to see 
how the PCNA loading on TNR-containing substrate impair the strand-specific MMR 
capability and how such defects influence TNR instability.    
 MMR proteins are also required for class switch recombination (CSR) of antibody 
genes in B cells (284–286). In the model of MMR-mediated CSR, Msh2-6 is critical for 
recognizing the U:G mismatches created by AID, a cytosine deaminating enzyme. The U:G 
mismatch bound by Msh2-6 recruits downstream factors such as PCNA, Mlh1-Pms2, and 
ExoI (284, 287). Interestingly, the MMR proteins promote double-strand breaks (DSB) at 
the switch repeat regions of the Ig genes. The ATPase and endonuclease activity of Mlh1-
Pms2 seem to play critical roles in DSB formation during CSR (286). Moreover, the 
ATPase activity of Mlh1-Pms2 influences DNA end processing and triggers non-
homologous end joining (NHEJ) by recruiting other interacting partners such as DNA-
PKcs (286, 288). Further studies are needed to understand the mechanisms by which Mlh1-
Pms2 promotes CSR in both upstream and downstream of DSB and its role in favoring 
NHEJ. 
 
 In Chapter 5, I have shown that IDR-containing TFs condense DNA molecules into 
puncta and discussed the role of nucleosome barriers in active enhancer domains for gene 
transcription. The observations that TFs mediate DNA condensation via PrLD interactions 
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opens many questions in the phase separation and SE fields. For example, how does the 
transcriptional machinery perform active transcription on DNA condensed by these TFs in 
vivo? A recent study has suggested that heterochromatin protein 1 (HP1) forms phase-
separated droplets and compact heterochromatin DNA into puncta, suggesting a role of the 
HP1-driven condensates in gene silencing (289). Then, what factors make the 
transcriptional apparatus dynamic and accessible during transcription by RNA polymerase 
II in euchromatin? If nucleosomes regulate function, how is nucleosome density 
determined and maintained so that it makes a local DNA dense enough for close proximity 
among regulatory sequences but also makes the region loose enough for efficient gene 
activation by a transcription machinery? It is well established that histone acetylation 
loosens condensed chromatin and specific histone marks, such as acetylation of histone H3 
lysine 27 (H3K27ac) or H3 lysine 56 (H3K56ac), are enriched in active enhancers (290, 
291). It would be interesting to see how such histone acetylation may either promote or 
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